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1 Abstract 
 
The methylotrophic yeast Pichia pastoris is successfully used for 
recombinant protein production. The application of strong promoters (e.g. 
the glyceraldehyde-3-phosphate dehydrogenase promoter PGAP, and the 
alcohol oxidase promoter, PAOX) and efficient secretion signals (alpha 
mating factor secretion leader; MFα1pp) as well as proper folding and post- 
translational modifications are beneficial. 
The extracellular protein X (Epx1) was detected as unknown, strongly 
secreted host protein in supernatants. As one of 20 endogenous secreted 
proteins in P. pastoris, little is known about Epx1 except C-terminal 
alignment with the SCP-like (secretory cysteine rich) extracellular protein 
domain. Therefore, the practicability as novel secretion system for 
enhancing recombinant protein expression was tested. The promoter 
sequence (1,000 bp upstream of ATG) was used to analyze intracellular 
eGFP expression. The Epx1 promoter, tested at three different carbon 
sources, was weaker in expressing eGFP compared to PGAP. Furthermore, 
secretion and processing mediated by Epx1 secretion leader was studied on 
three structurally and functionally different recombinant proteins: pTRP 
(porcine trypsinogen), HSA (human serum albumin), and eGFP (enhanced 
green fluorescent protein). 
The full length pre-pro Epx1 secretion leader partially showed 
processing difficulties. 21 amino acids at the pro-sequence remained N-
terminally attached due to unexpected cleavage at the internal dibasic motif. 
By shortening the Epx1 leader, pTRP secretion was increased, and eGFP 
was secreted without N-terminal overhangs. Summarizing, we established a 
novel and more efficient secretion leader than the MFα1pp, by shortening 
the Epx1 pro-sequence. 
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2 Introduction 
2.1 The methylotrophic yeast Pichia pastoris 
 
The methylotrophic yeast Pichia pastoris is widely used as a host 
system for recombinant protein production. It is also a commonly used 
model organism for basic research of peroxisome and secretory organelles 
biosynthesis. Furthermore, it has come into focus for the production of 
glycol-proteins with human-like N-glycan structures (Hamilton et al., 2003), 
as well as for several metabolites and recombinant proteins. 
Recently, P. pastoris has been reclassified into a new genus, namely 
Komagataella (Yamada et al., 1995), and divided into three species, K. 
pastoris, K. phaffii, and K. pseudopastoris (Kurtzman, 2005). The strains 
GS115 and X-33 have been made available by Invitrogen and belong to the 
species K. phaffii. Apart from that, other strains belonging to either K. 
pastoris or K. phaffii are freely used by researchers. The reference strain for 
all available P. pastoris strains (DSMZ 70382) belongs to the type species 
K. pastoris (Figure 1). Moreover, in accordance with published literature, all 
strains are further named P. pastoris, standing for the entire genus 
Komagataella. 
 
At present, the genomes of two P. pastoris strains (DSMZ 70382 and 
GS 115) have been fully sequenced (De Schutter et al., 2009; Mattanovich 
et al., 2009b). Therefrom, two genome browsers were set up (Mattanovich 
et al., 2009a). Until then, most data on genetic and physiological 
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background for strain- and process design relied on analogies to other, well 
studied yeasts like Saccharomyces cerevisiae. Accordingly, P. pastoris 
gene names follow mainly the format established for S. cerevisiae.  
Generalizing, the number of functionally annotated genes (9.4 Mb; 
5.450 ORFs) is comparable to other yeasts, most metabolic enzymes are 
present in single copies, and the number of actually secreted proteins is 
low, thus making secretory production of heterologous proteins attractive. 
 
2.2 Recombinant protein production in Pichia pastoris 
The use of P. pastoris as a cellular host for recombinant protein 
production steadily increases. It is genetically easy manipulated and 
cultured, and can reach high cell densities (> 130 g l-1 dry cell weight) on 
methanol and glucose (Cereghino & Cregg, 2000).  
Equally important, as eukaryote, it provides the potential for producing 
soluble, correctly folded proteins, which have undergone post-translational 
modifications, such as glycosylation (O- and N-linked; less over-
glycosylating than S. cerevisiae), disulfide bridge formation, as well as 
processing of signal sequences.  
For intracellular expression, the amino-terminal methionine residue is 
cleaved off, unlike proteins expressed in E. coli, or the protein can also be 
acetylated and specific amino acid residues are likely to be phosphorylated, 
generating phospho-proteins (Daly & Hearn, 2005) without limitations and 
bottlenecks obtained by the secretory pathway. Summing up, recombinant 
proteins can either be secreted, thus generating a more desirable amount of 
protein and simultaneously mediating the first step of purification, or 
intracellular expressed; this choice will depend on how the protein is being 
expressed in its native system. 
 
Transformation of the haploid, homothallic P. pastoris host with 
recombinant DNA is mediated either by integrative plasmids or by 
autonomously replicating plasmids. Directed integration or replacement 
requires homology of the introduced DNA with a chromosomal locus. 
Multiple integrations are often obtained on purpose (Porro et al., 2005). 
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Integration only requires restriction at a unique site, homologous to the P. 
pastoris genome. Transformation is mediated by electroporation and usually 
results in genetically stable transformants with high transcription rates (Daly 
& Hearn, 2005).  
Most vectors are hybrids between bacterial and yeast sequences, 
possessing an origin of replication for E. coli and selection markers. The 
plasmids also contain a multiple cloning site (MCS). Both auxotrophic 
markers, such as the functional histidine dehydrogenase gene (HIS4; first 
described by Cregg and colleagues (Cregg et al., 1985)), which can be used 
in histidine dehydrogenase defective GS115, as well as dominant markers 
exist. The bacterial kanamycin resistance gene also confers resistance to 
the eukaryotic antibiotic G418 and the bacterial Sh ble gene applies 
resistance to the antibiotic Zeocin™, also appropriate for yeast (Cereghino 
& Cregg, 2000).  
 
Further benefits of the P. pastoris system are strong inducible and 
constitutive promoter systems. One important issue of recombinant protein 
production is the transcription efficiency; therefore, the choice of the 
promoter is crucial. The number of available promoters is limited, however, 
and mainly comprises the methanol inducible alcohol oxidase 1 (AOX1) 
promoter and the constitutive glyceraldehyde-3-phosphate dehydrogenase 
(GAP) promoter. 
The P. pastoris alcohol oxidase and two other methanol regulated 
genes have first been isolated by Ellis and co-workers (Ellis et al., 1985). 
Alcohol oxidase is the key enzyme in the methanol utilization pathway; 
specific for methylotrophic yeasts. It is encoded by two genes, AOX1 and 
AOX2, and functionally and structurally characterized (Koutz et al., 1989) as 
well as reviewed several times. The AOX promoters are tightly regulated by 
a carbon source-dependent repression/induction mechanism; showing full 
repression during growth on glucose or glycerol excess conditions, and 
maximal induction during growth on methanol.  
In contrast, the glyceraldehyde-3-phosphate dehydrogenase promoter 
(PGAP) is constitutively expressed, although its strength varies depending on 
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the carbon source used for cell growth. This offers an attractive alternative 
to PAOX1 on glucose, especially if induction by methanol may be 
inappropriate or inconvenient; simultaneously increasing cell viability. 
Furthermore, the activity of PGAP in glucose-grown shake-flask cultures is 
stronger than PAOX1 in methanol-grown shake-flask cultures (Waterham et 
al., 1997) and slightly lower on methanol (Stadlmayr et al., 2010). 
Identifying alternative promoters is a promising and important tool 
especially for co-expressing recombinant proteins. Additionally, through 
regulation of transcription, promoters with varying activities increase host 
engineering possibilities. Auxiliary constitutive promoters include PTEF1 
(translation elongation factor 1-α) (Ahn et al., 2007), PPGK1 (glycolytic 
enzyme 3-phosphoglycerate kinase) (de Almeida, de Moraes & Torres, 
2005), and PYPT1, a GTPase involved in secretion (Sears et al., 1998). The 
formaldehyde dehydrogenase promoter (PFLD1), on the other hand, is 
inducible by both methanol and methylamine (Shen et al., 1998), whereas 
the isocitrate lyase promoter (PICL1) is inducible by glucose or ethanol 
(Menendez, Valdes & Cabrera, 2003). Recently, the auspicious promoter of 
a protein involved in synthesis of the thiamine precursor 
hydroxymethylpyrimidine (PTHI11) has been identified by Stadlmayr and co-
workers (Stadlmayr et al., 2010). It appears to be the first carbon and 
nitrogen source independent adjustable promoter. A major focus of several 
researchers is therefore the identification of new applicable promoter 
sequences. 
 
2.3 The secretory pathway, protein folding and secretory 
capacity of P. pastoris 
Heterologous proteins as well as endogenous proteins, dedicated to 
secretion, enter the endoplasmatic reticulum (ER). In P. pastoris, 88 
proteins were predicted as secreted proteins and thereof, 55 had been 
functionally annotated out of 172 ORFs, which had been identified to 
encode proteins entering the secretory pathway. However, experimental 
determination (chemostat culture on glucose as limiting carbon source) 
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revealed only 20 actually secreted proteins as shown in Figure 2 
(Mattanovich et al., 2009b). 
The first step in targeting proteins co-translationally to the ER is 
mediated through an N-terminal signal sequence (discussed detailed in the 
next chapter), which is recognized by the signal recognition particle (SRP) 
after emerging from the nascent protein. The tightly bound SRP targets the 
translation machinery to the cytosolic side of the ER membrane (Walter & 
Johnson, 1994). There, it interacts with the SRP-receptor, a component of 
the hetero-trimeric Sec61/62/63 
translocon complex with GTPase 
activity, thus mediating direct transport 
through the ER membrane into the 
lumen after a brief elongation arrest. 
The ER lumenal signal peptidase, 
which is attached to the translocon on 
the lumenal side, recognizes and 
cleaves off the signal peptide. 
Secretory proteins, however, require a 
second sequence for targeting the 
polypeptide further, generally termed 
as pro-peptide. Nevertheless, folding 
starts as soon as the polypeptide 
emerges from the translocon. 
ER resident folding factors assist 
in folding and quality control, such as 
the heat shock chaperones (Hsp70s) BiP as well as GRP170 and their 
yeast equivalents Kar2p and Lhs1p (Gething & Sambrook, 1992). They 
sustain ER residency by a C-terminal retrival sequence (HDEL in yeast), 
bind to hydrophobic sequences on nascent proteins and maintain vectorial 
protein translocation through an ATPase activity, supported by J-domain 
containing co-chaperones (Hsp40; Sec63p, Scj1p and Jem1p) and the 
nucleotide exchange factor Sil1p in yeast (van Anken & Braakman, 2005). 
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Perhaps the most distinctive feature of protein folding in the ER is the 
formation of disulfide bonds. Protein disulfide isomerase (PDI, a thiol 
oxidoreductase) catalyzes thiol-oxidation, reduction or isomerization. In 
yeasts, reduced Pdi1p is oxidized by Ero1p (ER oxidoreductase). 
Additionally, glutathione serves as reducing buffer that balances Ero1p 
activity (Tu & Weissman, 2004). Altogether, the list of PDI-like family 
members and other involved proteins has been growing steadily, hence 
enabling no universal folding strategy, but explaining the variety in speed 
and efficiency of folding (Kimura et al., 2005). Furthermore, it has been 
shown that BiP and Pdi1p act synergistically in the in vitro folding of a 
denatured and reduced Fab fragment, suggesting that BiP keeps the 
antibody chains accessible for Pdi1p (Mayer et al., 2000). 
Apart from that, glycosylation can be added to target proteins; O-
oligosaccharides (in the Golgi apparatus) or N-oligomannosyl-glycans (in 
the ER and Golgi apparatus). Despite the differences of glycosylation, there 
is evidence for a consensus recognition sequence for N-glycosylation in all 
eykaryotes, i.e. the sequon Asn-Xaa-Ser/Thr (Xaa any amino acid except 
proline) at the protein N-terminus (Macauley-Patrick et al., 2005). Glycans 
lead to more hydrophilic proteins and moreover, acting as a quality control 
mechanism even though they are trimmed and modified shortly after 
addition (van Anken & Braakman, 2005). 
ER clients exit via COPII coated vesicles from the entire ER, if quality 
control standards are implemented. In yeasts, the membrane protein Erv29 
determines that the soluble ER clients MFα1 pheromone and 
carboxypeptidase Y (CPY) are packaged and sent to the Golgi in 
accordance to hydrophobic sequences within the pro-sequence (Otte & 
Barlowe, 2004).  
On the other hand, misfolded ER substrates are retro-translocated to 
the cytosol and become subject to ubiquitination and subsequent 
proteasomal degradation; a process called ER associated degradation 
(ERAD). If the folding load increases or productive folding is hindered, the 
unfolded protein response (UPR) pathway is switched on; sensed by the 
endonuclease Ire1p. After the Ire1p-mediated splicing of HAC1 mRNA, 
15 
 
Hac1pi acts as transcription factor leading to up-regulation of UPR target 
genes, such as chaperones (Patil & Walter, 2001). 
 
In the Golgi apparatus, precursor processing and sorting mechanisms 
take place, concluding in targeting the proteins to the plasma membrane, 
endosomal compartments, the vacuole or via retrograde transport to the ER 
(Figure 3).  
The fungal Kex2 protease (a subtilisin-like serine proteinase) is located 
in the late Golgi network as well as in the endocytic, pre-vacuolar 
compartment. It acts during pheromone maturation at lysine-arginine motifs, 
extensively studied in processing prepro α-factor of S. cerevisiae and killer 
toxin K28. Kex2p as well as the mammalian equivalent furin undergo 
autocatalytic activation at an analogous site having the sequence Lys-Arg 
(Leduc et al., 1992; Wilcox & Fuller, 1991). 
Several studies have been carried out in S. cerevisiae kex2 mutants, 
unraveling severe drawbacks, but also observing cellular backup 
mechanisms. Especially furin and aspartyl-like proteases, such as yapsins, 
a family of glycosylphosphatidylinositol (GPI) anchored aspartic proteases 
(discussed below), show occasional processing at sites consisting of single 
basic residues (Steiner et al., 1992) and partial processing coverage within 
kex2 mutants (Bourbonnais et al., 1991). 
Generally, the preferred processing site of subtilisin-like serine 
proteinases depends on the amino acids surrounding the processing site 
(Lys-Arg or less frequently Arg-Arg, Arg-X-X-Arg or Arg-X-Lys, succeeded 
by negatively charged or small residues in the P1´ [C-terminal right after the 
processing side], P2´ and P4´ position) as well as the three dimensional 
structure (Bader, Krauke & Hube, 2008). Glu-Ala respectively Asp-Ala 
repeats C-terminal of the cleavage site have been known already to 
enhance Kex2p activity. Additionally, they ensure that these precursor 
portions will be exposed on the outer surface (Brake, Julius & Thorner, 
1983). 
Those repeats improve correctly processed proteins by preventing steric 
hindrance of the Kex2p cleavage site and are removed by the 
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diaminopeptidase (Ste13), also localized in the late Golgi. For high yield 
recombinant protein production secreted by prepro α-factor, Ste13p might 
be unable to cope with processing, leading to a protein fraction with Glu-Ala 
amino terminal extensions. Noteworthy, those extensions on recombinant 
proteins may also create dominant immunogenic sites. 
Two general pathways have been reported for protein secretion from 
the Golgi (Figure 3): a direct route and one via endosomes. Sorting to the 
endosome can follow targeting to the late endosome, which is also referred 
as multi-vesicular body (MVC) or pre-vacuolar compartment (PVC) via CPY 
pathway (soluble vacuolar hydrolase carboxypeptidase Y) or targeting the 
early endosomes. A third route directs the vacuole via alkaline phosphatase 
(ALP) pathway, named after its most studied cargo protein (Bowers & 
Stevens, 2005; Conibear & Stevens, 1995) 
 
In S. 
cerevisiae, Ste13p 
and Kex2p are 
localized within 
the same 
compartment 
(Bryant & Boyd, 
1993) and have 
been reported to 
spend a 
proportion of their 
time in different 
retrieval or 
recycling 
pathways between the late Golgi network and the PVC. Golgi retention is 
guaranteed by a late Golgi localization sequence which is recognized by 
receptors (e.g. Vps10p and Grd19p) (Bowers & Stevens, 2005; Voos & 
Stevens, 1998). 
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It was also reported that Kex2p itself (soluble or Golgi persistent) takes 
part as a saturable limiting component in the secretory and sorting pathway. 
As a result, secretion of insulin was increased after substituting dibasic 
sites, as well as by vps and kex2 deletions, suggesting endoproteolytic 
processing and sorting of Kex2p being the main cause for insulin retention 
and mislocalization to the vacuole (Zhang  et al., 2001). 
 
Vacuolar protein sorting has been studied extensively in S. cerevisiae, 
unraveling the role of more than 70 proteins involved in sorting, directing 
and secretion (61 currently known VPS genes). Additionally, the yeast 
vacuole is involved in degradation of plasma membrane-, cytosol- or 
organelle-derived proteins, ion storage, homeostasis maintenance and 
adaption to several stress factors (Li & Kane, 2009).  
Protein secretion is mediated through post-Golgi secretory vesicles that 
dock and fuse with the plasma membrane through interaction with v-
SNAREs and t-SNAREs. The cargo is then released outside after fusion of 
exosomes with the plasma membrane by help of the exocyst, the 
cytoskeleton and Rab GTPases (Burchfield et al., 2010). 
 
Misfolded proteins are translocated from the ER to the cytosol. 
However, some proteins are reported to enter the Golgi before they retrieve 
ERAD, and have been shown to enter the vacuole, using autophagic 
pathways via the cytosol. Some misfolded proteins that evade ER quality 
control or lack a further targeting sequence are transported to the vacuole 
using the classical secretory pathway, pointing out the vacuole system as a 
prominent counterpart in UPR and stress response (Kawaguchi, Hsu & Ng, 
2010; Li & Kane, 2009; Roberts, Nothwehr & Stevens, 1992). In plants, BiP 
was suggested to carry an additional vacuolar sorting signal, which enables 
an adaptor function between ill-defined hydrophobic regions of misfolded 
proteins and the sorting machinery, especially Vps10p, which recognizes 
hydrophobic regions in proteins subjected to vacuolar targeting (Pimpl et al., 
2006). 
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Internal stress has been identified as ratelimiting for secretion of 
recombinant proteins leading to several consequences, such as protein 
misdirection. Hohenblum and colleagues (2004) reported that human 
trypsinogen intended for secretion accumulates in the cytosol when 
expressed under control of PGAP on glucose, compared to methanol using 
PAOX1, where accumulation was only shown in the ER. Intracellular 
expression of heterologous Hnl (hydroxynitrile lyase) resulted in 50 % of the 
total cytosolic proteins in S. cerevisiae, whereas secretion by addition of 
signal leaders resulted in accumulation of Hnl at the plasma membrane 
(Hasslacher et al., 1997). The stress in recombinant protein producing yeast 
has been reviewed in detail by Gasser and colleagues (2008), discussing 
several topics, but also noting the phenomenon of variability within 
populations and therefore the existence of sub-populations with quite 
distinct features influencing the outcomes (Mattanovich et al., 2004). 
 
Additional factors that influence protein production include site and 
mode of integration of foreign sequences, mRNA 5´- and 3´ untranslated 
regions (UTR), translational start codon context, A+T composition of cDNA, 
nature of secretion signal, endogenous protease activity, host strain 
physiology, yeast codon bias (Sreekrishna et al., 1997) as well as media 
and growth conditions (Maurer et al., 2006). Codons that are common in 
other species, such as mammals, may be rare in P. pastoris. Altering the 
codon bias and therefore increasing the GC content within the DNA can be 
used to improve expression levels (Daly & Hearn, 2005). The recombinant 
proteins, as well as α-MF prepro leader sequence used in this study, 
therefore were codon optimized for P. pastoris. 
 
 
2.4 Selection of secretion signals in the Pichia pastoris 
expression system 
Signal sequences follow a common structural motif. The preregion 
typically consists of a positively charged N-terminus, followed by a 
hydrophobic middle sequence and a polar C-terminus. It targets the nascent 
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polypeptide to the ER via SRP dependent, SRP independent or both 
pathways, which is regulated by the hydrophobicity of the core sequence 
(Ng, Brown & Walter, 1996). In this context, increasing hydrophobicity was 
reported to augment protein secretion of human lysozyme in S. cerevisiae 
(Yamamoto et al., 1987), however, failed to improve secretion of chicken 
lysozyme in P. pastoris (Oka et al., 1999). The signal peptidase cleavage 
site is most often followed by three hydrophobic amino acids (Ala-Phe-Val), 
preceded by a basic residue, determining the pro-region of varying length 
and amino acid composition.  
 
 
2.4.1 Saccharomyces cerevisiae mating factor alpha 
In S. cerevisiae, the α-factor structural genes MFα1 and MFα2 and their 
role in mating have been studied extensively (Brake et al., 1983; Brake et 
al., 1984; Kurjan, 1985). The mating factor alpha gene 1 (MFα1) encodes a 
potent precursor (the prepro α-factor) of 165 amino acids that consists of a 
19 amino acid signal peptide, a 64 amino acid pro region containing three 
sites for N-linked glycosylation, followed by four tandem repeats of the 
mature α-factor pheromone preceded by a spacer peptide. The nascent 
polypeptide is SRP-independently translocated into the ER, where the 
signal peptide is cleaved off and the three Asp sites within the pro-region 
are glycosylated, which however is not essential (Caplan et al., 1991; 
Chaudhuri, Latham & Stephan, 1992). Further modifications occur at the 
late Golgi, where Kex2p cleaves at dibasic sites, followed by Ste13p 
removal of hydrophobic spacer sequence (mostly two repeats of Glu-Ala) 
(reviewed in Porro et al., 2005).  
 
MFα1pp is the most extensively used secretion leader for secretion of 
foreign proteins in yeast, such as human epidermal growth factor (Brake et 
al., 1984), insulin-like growth factor 1 (Chaudhuri et al., 1992), full-length 
antibodies (Rakestraw et al., 2009), cellulase endoglucanase (Zhu, Yao & 
Wang, 2010) and many more in S. cerevisiae as well as in various other 
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yeasts such as P. pastoris (Porro et al., 2005). Naming all would extend the 
scope of this prologue. 
Generally, the MFα1pp obtains the most promising results and 
production rates and is in most cases even more efficient than native signal 
peptides (Zhu et al., 2010). Unfortunately, folding and processing 
sometimes hassles and the N-terminal (Glu-Ala)2 overhangs influence 
quantity and quality of secreted proteins. However, the MFα1 pro-sequence 
can also be omitted, leading to correct N-termini (Zhao et al., 2009). 
 
 
The MFα1pp spacer has ambivalent impact on heterologous protein 
production, such as preventing intracellular accumulation by decreasing 
biological activity (Brake et al., 1984), decreasing the enzymatic activity of 
lysozyme (Oka et al., 1999), and exposure of sequence to further 
processing enzymes (Brake, et al., 1983) as well as generation of N-
terminal ragged ends and increased immunogenicity due to partial cleavage 
by saturated Ste13p, even though Kex2p processing is increased by the 
spacer peptide (Parekh, Forrester & Wittrup, 1995). To overcome 
processing difficulties leading to saturation of enzymatic capabilities and 
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mislocalization, many attempts have been made. A directed evolution of the 
alpha mating factor 1 leader peptide (MFα1pp) yielded a 16-fold secretory 
improvement over the wild type MFα1pp (Figure 4a), hence identifying two 
accountable mutations (Figure 4b; position 22 and 63-66 in the pro-
sequence) (Rakestraw et al., 2009).  
In designing secretion systems for heterologous proteins, one aims to 
maximize both the yield and fidelity of the product, and therefore the use of 
other secretion leaders might be more advantageous (Sleep, Belfield & 
Goodey, 1990). 
 
2.4.2 Other used signal sequences 
P. pastoris and S. cerevisiae have low specificity for recognition of 
signal sequences and therefore, the recombinant proteins’ native signal may 
also be used successfully for protein expression. A ribosome inactivating 
protein from Aspergillus giganteus (α-Sarcin) has been successfully 
secreted in P. pastoris with its native signal sequence, but not in S. 
cerevisiae. A single mutation of the leader peptide, generating a more 
favored Kex2p recognition site, enhanced processing and secretion of α-
Sarcin (Martinez-Ruiz et al., 1998). Human serum albumin (HSA) was 
efficiently secreted by its native leader (Kobayashi, 2006). Additionally, 
human lysozyme was directed correctly processed to the supernatant in P. 
pastoris by the HSA native signal leader (Xiong & Chen, 2008) and the 
chicken lysozyme native leader (Oka et al., 1999). The matrix 
metalloproteinases-1, 2, 3, 9 signal peptides are also functional in the P. 
pastoris system (Sreekrishna et al., 1997). Additionally, the plant lectin 
Phaseolus vulgaris agglutinin (PHA; both E- and L-forms) signal sequence 
was used to secrete correctly processed PHA and GFP in P. pastoris 
(Raemaekers et al., 1999). 
 
Recently, a C-terminal truncated envelope protein from Dengue-2 virus 
has been targeted to the ER for further folding through the S. cerevisiae 
sucrose invertase 2 (Suc2) signal sequence in P. pastoris (Valdes et al., 
2007). This signal sequence was also used for hepatitis C virus structural 
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viral protein (Martinez-Donato et al., 2006) and A. niger xylanase expression 
(Berrin et al., 2000) in P. pastoris, just to name a few. Protein secretion was 
also obtained by using a viral secretion signal derived from the K28 prepro 
toxin, the precursor of the yeast K28 virus toxin in P. pastoris (Eiden-Plach 
et al., 2004) as well as by using the P. pastoris Pho1 (acid phosphatase 1) 
secretion signal, containing a Kex2p cleavage site (Laroche et al., 1994). 
 
To this end, usage of MFα1pp is mostly improving heterologous protein 
secretion compared to other or native secretion signals; however, fractions 
with N-terminal amino acids of the leader are often remaining. Different 
other prepro sequences were tested in P. pastoris, leading to various 
outcomes compared to the MFα1pp. Generally, the optimal secretion leader 
should be adjusted specifically for every recombinant protein as the leader 
influences folding and secretion. The establishment and characterization of 
novel powerful secretion signals is therefore a common and feasible goal for 
biotechnology applications and understanding yeast physiology. 
 
2.5 Extracellular protein X; a member of the SCP-like (secretory 
cysteine-rich) protein super family  
As previously reported, experimental determination revealed 20 actually 
secreted proteins (Mattanovich et al., 2009b) in P. pastoris. The most 
abundant one of them, PIPA00934, was predicted to be secreted by SignalP 
platform, but lacks an N-linked glycosylation site or transmembrane area. 
PIPA00934 is a member of the SCP–like (secretory cysteine-rich) protein 
super family with unknown function, it has a theoretical pI of 5.55 and a 
molecular weight of 31.72 kDa (Figure 5).  
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During several laboratory and large scale fermentations for 
heterologous protein production, a prominent unidentified host cell protein 
band at about 70 kDa was observed in P. pastoris supernatants. N-terminal 
sequencing of this protein revealed that it equals the PIPA00934-gene 
product; however it is present as dimer extracellularly and therefore 
migrates slower as predicted on SDS-PAGE. Little was known about this 
protein, named extracellular protein X (Epx1), thus it caught attention and 
interest because of its high secretion rates. 
Subsequent NCBI-BLAST analysis of Epx1 revealed no clear statement 
concerning full alignment with a specific protein domain. Only the C-terminal 
half was dedicated to the SCP superfamily, which includes plant pathogen 
related (PRY) proteins, Golgi-associated PRY proteins and several 
hypothetical proteins in all kinds of species, such as its homologue Pry2p in 
S. cerevisiae (Figure 6).  
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This super family also includes mammalian cysteine-rich secretory 
proteins (CRISP), moreover having a signal peptide for secretion and a 
conserved cysteine-rich domain. In yeast, the Cys-rich domain is not 
conserved. PRY proteins in plants are divided into 17 major groups with 2 
subclasses, whereof one comprises an acidic subclass that usually is 
secreted to the extracellular space and the other specifies deposition into 
the vacuole. Antifungal activity of PR-5 in plants is suggested according to 
their permeabilization of fungal plasma membrane, but not completely 
understood so far (Kitajima & Sato, 1999). Human Golgi-associated plant 
pathogenesis related protein (GAPR-1) mainly forms a membrane-bound 
dimer, generating a possible catalytic triad across the interface of the dimer 
structure (Serrano et al., 2004a). 
 
Most prohormones and precursors in higher eukaryotes are processed 
in dense core secretory vesicles at dibasic sites by the prohormone 
convertase (PC)/furin family, which are structurally analogous to Kex2p, 
except that the Ser/Thr-rich domain in Kex2p was replaced by a cysteine-
rich domain and some are likely to be soluble proteins within the late Golgi. 
For mammalian PC3, it was also shown that it undergoes C-terminal 
processing, presumably at one of several pairs of dibasic amino acids 100- 
200 residues before the C-terminus (Steiner et al., 1992). 
Yapsins, members of aspartic proteases, were first explored as 
monobasic-specific cleavage enzymes and kex2p compensating 
endopeptidases (Steiner et al., 1992), and their deletion rather than their 
over expression has been useful in heterologous protein production (Cho et 
al., 2010). Notably, there are several examples of prohormones in which the 
processing site occurs at a single Arg site, e.g. the somatotropin releasing 
inhibitory factor (SRIF) which is endoproteolytically activated at a single Arg 
or internal dibasic cleavage site (Arg-Lys), generating two functionally 
different peptides (Bourbonnais et al., 1991). The fungal yapsin Sap9 has 
been indicated to enclose an autocatalytic processing ability (Albrecht et al., 
2006). 
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The function of yapsins has yet not been fully elucidated, but presumed 
in cell surface integrity. They divert greatly among eukaryotes, but comprise 
a signal peptide, a pro-peptide of variable length boarded by dibasic 
residues (which might occupy the active site cleft in the inactive precursor 
and serves as sorting signal or chaperone), a conserved catalytic center, 
presence of disulfide bridges for dimerization, a loop with high Ser/Thr 
content and a GPI anchor, even though many aspartic proteases are 
soluble proteins (Gagnon-Arsenault, Tremblay & Bourbonnais, 2006). They 
are synthesized as inactive zymogens and activated through cleavage at di- 
or monobasic sites, although the precise course of activation is not yet 
completely explained, and they might themselves be subjected to late 
activation at the cell periphery (Komano, Rockwell, Wang, Krafft, & Fuller, 
1999).  
The pepsin-like aspartic proteinase A (PrA) is essential to the yeast 
vacuolar system and targeted to the organelle as zymogen. Activation 
occurs, amongst others, via a step-wise auto-activation product known as 
pseudo-proteinase A in a transport vesicle en route to the vacuole; 
eventually mediated through an additional signal either within the pro-
segment, the mature molecule or both (Parr et al., 2007).  
 
Summing up, the role and mechanisms of extracellular protein X (Epx1) 
in P. pastoris is not clear at all. Nonetheless, Epx1 has a signal peptide and 
a pro-peptide, which includes a dibasic motive in the middle and a 
monobasic terminal motive, whereafter the sequence of mature extracellular 
Epx1 starts. It is then followed by a Ser/Thr-rich stretch. The last 100 
residues, including an additional dibasic C-terminal sequence, are 
homologous to SCP-like family, even though Epx1 contains only 4 cysteine 
residues (Figure 7). They might be involved in dimerization of Epx1 through 
disulfide bonding.  
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In contrast to other family members, Epx1 dimers were dominantly 
found in supernatant at recombinant protein production in P. pastoris. Epx1 
neither has a transmembrane domain, nor a GPI-anchor. It is however 
unclear how i) Epx1 is up-regulated especially in recombinant protein 
production strains, ii) processing and function of propeptide works and iii) 
how and why Epx1 exists as dimers extracellularly. 
 
3 Aim of the study 
The aim of the study is the biotechnological application of Epx1 
promoter and secretion leader to the P. pastoris host properties on 
recombinant protein production, and the investigation of underlying 
mechanisms of strong Epx1 secretion. Secretion leaders show diverse 
impact on particular recombinant proteins, therefore three structural and 
functional different proteins are extracellularly and intracellularly analyzed.  
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4 Material and Methods 
4.1 Bacterial Strains 
As bacterial hosts, the Escherichia coli strains Top10, JM107 or DH10B 
were used (Table 4.1.1). In order to transform E. coli with particular 
plasmids, either electrocompetent or chemical competent cells were 
prepared. 
 
4.1. 1: Bacterial strains used for transformation 
 
4.1.1 Preparation of electrocompetent Escherichia coli 
A single E. coli Top10 or JM107 colony was inoculated in 10 mL LB-
medium (per liter: 10 g soy peptone (QUEST), 5 g yeast extract (MERCK) 
and 5 g NaCl at pH 7.4 – 7.6, set with 4 M or 8 M NaOH) and incubated 
over night at 37°C under vigorous shaking. 
The main culture (500 mL LB-medium) was inoculated with preculture, 
approximately generating a start OD600 of 0.1. After growing at 37°C for 
several hours to a final OD600 of 0.5 – 1, the culture was transferred into a 
sterile, precooled centrifuge tube and put on ice for 10 min. Afterwards, the 
culture was centrifuged at 4,000 x g (BECKMAN Coulter, Avanti J-20 XP 
Centrifuge, rotor JLA-10.500) for 10 min at 4°C. 
The pellet was resuspended and washed three times with 1 mM 
HEPES, followed by another centrifugation for 10 min at 5,000 x g at 4°C. 
Thereafter, the pellet was resuspended in 20 mL 10 % (v/v) glycerol, 
Strain Reference/
Source 
Genotype 
Top10 Invitrogen F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 
recA1 araD139 Δ(araleu) 7697 galU galK rpsL (Str
R
) endA1 
nupG 
JM107 Fermentas F’ traD36 proA
+
B
+
 lacI
q
 ∆(lacZ)M15 / e14
–
 (McrA
–
) ∆ (lac-pro) 
endA1 gyrA96 (Nal
r
) thi-1 hsdR17 (rk
–
mk
+
) glnV44 relA1 
DH10B Invitrogen F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 
recA1 endA1 araD139 Δ(ara, leu)7697 galU galK λ- rpsL 
nupG 
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followed by another centrifugation and removal of supernatant. The pellet 
was then resuspended in 500 µL 10 % (v/v) glycerol. Aliquots à 100 µL were 
quick-frozen in liquid nitrogen and stored at -80°C. 
 
4.1.2 Transformation into electrocompetent E. coli 
The first few transformations were carried out with Top10 strain, 
whereas afterwards we switched to JM107. Plasmids were prepared as 
described below, purified via mi-PP200 (metabion) and eluted in 20 µL 
sterile 1 mM Tris/HCl pH 8, or sterile ddH2O. 
For each transformation (ligated empty vector backbone as negative 
control), one 100 µL aliquot was put on ice 15 min prior to transformation 
and the eluted, ligated plasmid was added to the cells. Transformation was 
performed using a BTX Electroporator (BTX-Harvard Apparatus ECM 830 
Square Wave Electroporator), a charging voltage of 2.5 kV, a resistance of 
1,000 Ω and a capacitance of 25 µF in an electroporation cuvette with a 4 
mm gap.  
Thereafter, cells were transferred into 1 mL sterile SOC-medium (per 
liter: 20 g soy peptone (QUEST), 5 g yeast extract (MERCK), 0.58 g NaCl, 
0.19 g KCl, 2.03 g MgCl2 x 6H2O, 3.96 g glucose monohydrate, 2.46 g 
MgSO4 x 7H2O) for a 30 min regeneration period. Then they were plated out 
in aliquots (50 µL, 200 µL and remains) on selective LB-agar plates (per 
liter: 10 g soy peptone (QUEST), 5 g yeast extract (MERCK), 5 g NaCl and 
20 g agar-agar (MERCK) at pH 7.4 – 7.6 set with 4 N or 8 N NaOH) 
containing 25 µg mL-1 Zeocin™, and inoculated for 24 h at 37°C. 
 
4.1.3 Preparation of chemical competent E. coli 
Chemical competent E. coli cells were prepared by first inoculating a 
single colony E. coli DH10B in 5 mL LB-medium overnight at 37°C under 
vigorous shaking. The main culture (200 mL LB-medium) was inoculated 
with preculture, approximately generating a start OD600 of 0.1. After growing 
at 37°C for several hours, to a final OD600 of 0.4 – 1, the culture was 
transferred into a sterile, precooled centrifuge tube and put on ice for 10 
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min. Afterwards, the culture was centrifuged at 3,000 x g (BECKMAN 
Coulter, Avanti J-20 XP Centrifuge, rotor JLA-10.500) for 15 min at 4°C. 
The pellet was resuspended in 50 mL FB-buffer (per liter: 7.4 g KCl, 7.5 
g CaCl2*2H2O, 100 g glycerol, 10 mL 1 M K-acetate at pH 7.5; sterilized by 
filtration afterwards) and incubated on ice for 45 min, followed by 
centrifugation for 15 min at 2,200 x g at 4°C. Thereafter, the pellet was 
resuspended in 15 mL FB-buffer. Aliquots à 150 µL were quickly transferred 
into precooled 1.5 mL Eppendorf tubes and stored at -80°C. 
 
4.1.4 Transformation into chemical competent E. coli 
For each transformation (ligated empty vector backbone as negative 
control), one 100 µL aliquot of chemical competent E. coli was put on ice 15 
min prior to transformation and the ligated plasmid was added to the cells. 
The reaction tube was put at 42°C for 30 s and immediately put on ice for 5 
min afterwards. 
Followed by a regeneration period in SOC-medium at 37°C, cells were 
plated out in aliquots (50 µL, 200 µL and remains) on selective LB-agar 
plates, containing 25 µg mL-1 Zeocin™, and incubated for 24 h at 37°C.  
 
4.1.5 Plasmid preparation 
Independent from the transformation protocol, transformation efficiency 
was recorded and several colonies were chosen for further analysis. Single 
cell colonies were picked and streaked out on selective LB-agar plates and 
further transferred to 2 mL selective LB-medium for 24 h at 37°C. 
The master LB-agar plate was stored at 4°C, whereas the overnight 
culture was used for plasmid Mini-Prep (mi-PM200, metabion), following the 
manufacturer’s instructions. Plasmids were eluted in 40 µL 1 mM Tris/HCl 
pH 8, or sterile ddH2O. 
Analytical restriction digestions with specific restriction endonucleases 
(supplied by Fermentas or New England BioLabs) were performed for 
verifying the expected plasmid by means of the DNA-fragments analyzed 
with gel electrophoresis (4.9).  
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After receiving the correct band pattern for the estimated plasmid size 
within one or more clones, the respective clone was used for inoculation of 
approximately 100 mL selective LB-medium and incubated overnight at 
37°C under vigorous shaking. 
The next day, cell pellet was harvested by centrifugation at 3,500 x g for 
15 min at RT (C312 Jouan). The supernatant was removed and plasmids 
were collected via Midi-Prep (HiSpeed® Plasmid Midi Kit (25), QUIAGEN, 
#12643), following the manufacturer’s instructions.  
Plasmids were eluted in 1 mL 1 mM Tris/HCl pH 8, or sterile ddH2O, 
and plasmid concentration was measured (NanoDrop 1000 
Spectrophotometer, Thermo Scientific) or determined by comparing the 
DNA concentration of 1 µL linearized plasmid with 5 µL MassRuler™ DNA 
Ladder Mix (Fermentas, SM0403). 
 
4.2 Preparation and transformation of electrocompetent P. 
pastoris 
For the yeast experiments, an electrocompetent Pichia pastoris strain X-
33 (Invitrogen, wild type strain; C180-00) was prepared.  
 
4.2.1 Preparation of electrocompetent P. pastoris X-33 
A single colony from a fresh P. pastoris X-33 agar-plate was inoculated 
in 5 mL sterile YPD-medium (per liter: 20 g yeast extract, 10 g soy peptone 
and 20 g glucose at pH 7.4 - 7.6) and incubated overnight at 28°C under 
vigorous shaking. 
The overnight culture was used to inoculate 200 mL YPD-medium, 
receiving an OD600 of 3 after an incubation time of 17 h. The therefore 
required inoculation volume of the preculture was calculated via x0 
according equation 1. 
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Equation 1: Calculating the inoculation volume via x0 
 
      
   
 
x OD600 main culture after time t 
x0 OD600 main culture at time of inoculation 
µ 0.347 h-1 for P. pastoris in YPD-medium at 28°C 
t incubation time 
 
After the determined cultivation time and reaching calculated cell 
density, the culture was transferred into a sterile, precooled centrifuge tube 
and centrifuged at 1.500 x g (approximately 3.000 rpm; BECKMAN Coulter, 
Avanti J-20 XP Centrifuge, rotor JLA-10.500) for 5 min at 4°C. The pellet 
was resuspended in 100 mL prewarmed YPD-medium containing 2 mL of 1 
M HEPES pH 8.0 and 2.5 mL of 1 M DTT. After incubation for 15 min at 
28°C on the rotary shaker (180 rpm), 400 mL icecold ddH2O were added 
and cells were harvested by centrifugation as described above. The pellet 
was washed with 250 mL sterile and icecold 1 mM HEPES. Cells were 
harvested by centrifugation and the pellet was resuspended in 20 mL sterile 
icecold 1 M D-sorbitol. Another centrifugation followed and the pellet was 
resuspended in 5 mL sterile, icecold 1 M D-sorbitol. Aliquots à 100 µL were 
stored at -80°C.  
 
4.2.2 Transformation of P. pastoris by electroporation 
For each transformation, one 100 µL aliquot of electrocompetent P. 
pastoris was put on ice 15 min prior to transformation. A small volume of 
linearized DNA (20 µL column purified plasmid; metabion, PCR purification 
Kit, mi-PP200) was added prior to electroporation. Plasmids were linearized 
and integrated into the genome, either within the AOX transcription 
terminator (AOXTT) (via AscI, R0558), or within PGAP (via AvrII, R0174) and 
PEPX1 (via NheII, R0131) if AOXTT was absent on the plasmid. 
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The cells were transferred to a pre-cooled electroporation cuvette with a 
2 mm gap. Transformation was performed using a BioRad Micropulser, a 
charging voltage of 2 kV and a pulse length of 4 ms.  
Thereafter, cells were transferred to sterile YPD-medium for 2 h 
regeneration period. Then, they were plated out in aliquots (50 µL, 100 µL 
and 200 µL) on selective YPD-agar plates (per liter: 20 g yeast extract, 10 g 
soy peptone, 20 g glucose and 20 g agar-agar) containing 25 µg mL-1 
Zeocin™ and incubated for 48 h at 30°C.  
 
4.2.3 Cultivation conditions for P. pastoris 
Transformation efficiency was recorded and several colonies were 
chosen for further analysis. Subsequently, single cell colonies were 
streaked out again on selective YPD-agar plates. One single cell colony per 
each clone was used for shake-flask experiments and about 12 individual 
clones were inoculated for 24 h in 5 mL selective YPD-medium. 
The optical density of preculture was determined, whereby 5-10 mL 
main culture was inoculated in 100 mL shake-flasks, generating a start 
OD600 of 0.1. Dependent on the experiment and examined recombinant 
heterologous protein, different media were used.  
 
For screening the eGFP expression under the control of PGAP and PEPX1, 
and for screening the secretion of pTRP under the control of PGAP and 
PEPX1, autoclaved complex-screening-medium was used (per liter: 10 g pea 
peptone, 10 g yeast extract, 10.2 g (NH4)2HPO4, 1.24 g KCl, 910 µL 1M 
CaCl2; pH set to 5 with 25 % [v/v] HCl) and 2 mL 500 x biotin and 100 mL 
10 x carbon-source (20 % [v/v] glucose, 10 % [v/v] glycerol or 10 % [v/v] 
methanol) were added before usage.  
Synthetic-screening-medium was used for analysis of pTRP under the 
control of PGAP with three different secretion leader sequences (per liter: 22 
g glucose, 22 g citric acid, 3.15 g (NH4)2HPO4, 0.027 g CaCl2*2H2O, 0.9 g 
KCl, 0.5 g MgSO4*7H2O, 2 ml 500 x biotin and 1.47 mL trace salts stock 
solution [per liter: 6 g CuSO4*5H2O, 0.08 g NaI, 3 g MnSO4*H2O, 0.2 g 
Na2MoO4*2H2O, 0.02 g H3BO3, 0.5 g CoCl2, 20 g ZnCl2, 5 g FeSO4*7H2O 
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and 5 mL H2SO4]; pH set to 5 with 5 M KOH and sterilized by filtration [0.22 
µm]). 
The shake-flask cultivation of clones secreting HSA with three different 
secretion leader sequences under the control of PGAP was performed with 
the synthetic-screening-medium too, but the pH was set to 6 for assuring 
increased stability of secreted HSA. 
The screening of eGFP secretion was performed with synthetic-
screening-medium at pH 5, but 12.6 g (NH4)2HPO4 were used instead. 
 
Shake-flask cultivation was carried out for 48 h at 28°C at 170 rpm. 
Every 12 hours cells were fed with 100 µL 50 x glucose; generating a total 
concentration of 3.5 % (v/v) glucose at screening end for yielding maximal 
20 g/L biomass. Likewise, 400 µl 10 x glycerol or 50 µL 100 x methanol 
were fed at carbon sources comparing experiments. 
Samples were taken either after 12 or 48 hours. Wet cell weight was 
determined per mL culture, and cell pellets as well as supernatant was 
directly used for further analysis or stored separately at -20°C in aliquots. 
 
4.3 Plasmids and cloning procedure 
The novel P. pastoris expression vector pPUZZLE was used, allowing 
easy exchange of vector components by restriction digestion and inserting 
different sequences (Stadlmayr et al., 2010). This E. coli/P. pastoris shuttle 
vector was used as vector backbone throughout this project. The artificial 
sequences were exchanged by using restriction sites (Figure 8), added via 
PCR to gene of interest (Table 4.4.1). Hence AOXTT had to be removed, 
because of its internal Pfl23II recognition sequence (which hindered pTRP 
insertion), and ZeoRlox site was exchanged by ZeoR. The Epx1 secretion 
leader sequences (native and shortened) were PCR amplified and 
integrated via PvuII, BglI or AccI.  
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4.4 Primer sequences 
Oligonucleotides were synthesized by metabion (100 pMol/µL) and are 
listed in Table 4.4.1. The calculated melting temperature (GC + AT Tm) was 
between 56 to 67°C, except primers used for amplifying the shortened Epx1 
secretion leader. 
For sequencing specific regions on plasmids, those primers were 
additionally used, as well as some more, which are listed here. Sequencing 
results obtained by MWG Eurofins were then analyzed via SeqMan™.  
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Table 4.4.1: Overview of forward and backward oligonucleotides with integration site for 
pPuzzle vector 
Forward Sequences 5´-3´ restriction site 
Epx1pp 
TATACCTGCAGGATGAAGTTCTCTACCAATTTG
ATC 
SbfI 
pEpx1 
ATTACGCCGGCGGCATCAAGGGTTCTGGATCT
C 
MreI 
(Sse232I) 
Epx1pp-
KR_pTRP 
ATACCAGCTGCTCCAGTTGCTCCAGCCGAAGA
GGCAGCAAACCACTTGCACAAGCGTTTCACTG
ACGACGACGACAAG 
PvuII 
Epx1pp-
RT_pTRP 
ATACCGTACGTTCACTGACGACGACGACAAG 
Pfl23II 
(BsiWI) 
αMF_eGFP ATGAGAATTCGTGAGCAAGGGCGAGGAGC EcoRI 
Epx1pp-
KR_eGFP 
ATACCAGCTGCTCCAGTTGCTCCAGCCGAAGA
GGCAGCAAACCACTTGCACAAGCGTGTGAGC
AAGGGCGAGGAGC 
PvuII 
Epx1pp-
RT_eGFP 
ATTTGTCTACCGAACTGTGAGCAAGGGCGAGG
AGC 
AccI 
Epx1pp-KR_HSA 
ATTCGCCGAAGAGGCAGCAAACCACTTGCACA
AGCGTGATGCACACAAGAGTGAGGTT 
BglI 
Epx1pp-RT_HSA 
AGGCGTCTACCGAACTGATGCACACAAGAGTG
AGGTT 
AccI 
   
Backward Sequences 5´-3´ 
 
pEpx1 
GATCCCTGCAGGTAGAATAGTGAACGTGTTTT
AAAG 
SbfI 
Epx1pp GAAGATGCATCGTACGGTAGACAGTGACAAC NsiI 
pTRP 
TTTTGGCCGAGGCGGCCTTTCAGTTAGCAGCG
ATAGTTTG 
SfiI 
αMF_eGFP 
TAGGGCGGCCGCTTACTTGTACAGCTCGTCCA
TG 
NotI 
eGFP 
CGTTGGCCGAGGCGGCCTTACTTGTACAGCT
CGTCCATG 
SfiI 
HSA 
GAGTGGCCGAGGCGGCCTTATAAGCCTAAGG
CAGCTTGA 
SfiI 
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4.5 PCR (polymerase chain reaction) 
DNA sequences from plasmid or genomic DNA were amplified. Primers 
with accessory endonuclease cleavage sites were used (Table 4.4.1), 
generating a fragment which can be easily integrated into existent plasmids. 
Generally we used a touch-down PCR method (Don et al., 1991) with 
BioRad DNA engine Peltier Thermal Cycler, starting 5°C above calculated 
annealing temperature and ending 5°C below, followed by 25 elongation 
cycles. One negative control (for every PCR setup) was prepared without 
template DNA. 
 
4.6 DNA-polymerases 
Polymerases with proof-reading function were used and PCR reaction 
mix varied according to polymerase, whereas dNTPs (10 mM, Fermentas, 
R0193) primers and sterile ddH2O remained unchanged.  
Most often Pfu DNA Polymerase (Fermentas, EP0502, 2.5U/µL) was 
used. The reaction setup in 50 µL ddH2O was: 5 µL 10 X Pfu Buffer, 4 µL 25 
mM MgSO4, 1 µL 10 mM dNTPs, 1.5 µL Primer FW, 1.5 µL Primer BW, 1 µL 
polymerase and 1 µL template. Denaturing temperature was 95°C and 
elongation time was 2 min/kb at 72°C due to 3´-5´ exonuclease activity 
(proof-reading).  
 
4.6.1 Generation of blunt ends 
Additionally, the generation of blunt ends was performed with T4 DNA 
polymerase (NEB, M0203, 3U/µL) with 5´-3´ fill-in and 3´-5´ exonuclease 
activity (very low error rate). Then, 1 µL T4 DNA Polymerase and 1 µL 
10mM dNTP were added, and incubated for 15 min at 12°C. Heat 
inactivation for 20 min at 75°C was beneficial. For ligation with another blunt 
end fragment, the larger fragment was treated with CIP (see below). 
Sequencing Sequences 5´-3´ 
Seq_GAP_forw ACCAGAATCGAATATAAAAGGCG 
pPUZZLE_bw_cycTT AATTACATGATATCGACAAAGGA 
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4.7 Digestion of DNA with restriction enzymes 
PCR product and vector 
backbone were cut with respective 
restriction endonucleases. Therefore, 
the full PCR mix was digested with 2 
µL per each enzyme (Fermentas or 
New England Biolabs), 5 µL buffer 
and 5 µL 10 x BSA (if required) for 
one hour. For preparative setups of 
plasmid DNA, 3 µL restriction 
endonuclease, buffer and BSA were 
added to 40- 80 µL plasmid DNA 
(High Speed® Plasmid Midi Kit, 
QUIAGEN, 12643, ca. 100 ng/µL) and incubated at the suggested 
temperature. After electrophoresis, desired bands were cut out and purified 
with a gel extraction kit (mi-GE100, metabion), following the manufacturer’s 
instructions. DNA was eluted in 40 µL 1 mM Tris/HCl pH 8 or sterile ddH2O. 
Digestion success and DNA amount (ng/µL) was checked by comparing 1 
µL digestion reaction with 5 µL MassRuler™ DNA ladder (Figure 9) via 
agarose gel electrophoresis prior to ligation. 
 
After ligation and successful transformation into E. coli, plasmid DNA 
(mi-PM200, metabion) of several clones was checked for expected band 
pattern of cleavage products of restriction digestion. Therefore, restriction 
mix (10 µL eluted plasmid, 5 µL buffer, 5 µL 10 x BSA (if required) and 1 µL 
endonuclease, ad 50 µL ddH2O) were incubated at the required 
temperature. 
 
4.8 Dephosphorylation and ligation of DNA fragments 
For decreasing self-ligation, the vector backbone was treated with CIP 
(Calf Intestine Alkaline Phosphatase, M0290, NEB, 1 U/µL). Therefore, 1-3 
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µL CIP were added to preparative restriction digestion reaction of plasmid 
DNA, as CIP works with all buffers. After incubation for 30 min at 37°C and 
heat inactivation for 10 min at 65°C, the restriction digestion reaction was 
purified by using mi-PP200 kit and eluted in 40 µL 1 mM Tris/HCl pH 8, or 
sterile ddH2O. 
DNA concentration was either determined by fluorospectrometer 
(NanoDrop 3300, Thermo Scientific) or by estimating concentration via 
agarose gel electrophoresis. For that purpose, 1 µL sample (either insert or 
cut vector backbone) as well as 5 µL MassRuler™ (Figure 9) were applied 
to an agarose gel. The concentration was estimated by comparing band 
intensity of samples with those of known concentrations of the DNA 
standard. According to equation 2, a ratio of 3/1 of vector/insert was used 
and ratio of “free ends” was comprised via kilo-base pairs.  
 
Equation 2: Calculating ligation setup 
       
  
    
                   
  
   
          
 
 
 
 
 
A ligation setup with total volume of 20 µL was prepared with 1 µL T4-
DNA Ligase (NEB, M0202, 400,000 U/µL) and 10 x T4 Reaction Buffer 
(NEB, B0204S) for 2 h at RT. Subsequently, ligation setup was purified 
using mi-PP200 kit and eluted in 20 µL sterile ddH2O, if transformation of 
electrocompetent E. coli followed. For transformation of chemical competent 
cells purification was not necessary.  
 
4.9 DNA gel electrophoresis 
For analysis of selective amplification of DNA fragments via PCR, for 
controlling DNA fragments after restriction digestion or preparation of 
fragments for ligation or transformation, DNA gel electrophoresis was used.  
Due to cost and health reasons, we switched from ethidium bromide to 
Midori Green during the course of this work. While working with EtBr as 
fluorescent dye, per gel (150 mL) 1 % agarose (Biozym, LE Agarose, 
840006), 1 x TAE and 6 µL EtBr were used. For Midori Green (NIPPON 
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Genetics Europe GmbH, MG02) we used 1.5 % agarose, 1 x TAE and 0.5 
µl per gel (100 mL). Additionally, fluorescent dyes were added to the EtBr 
running buffer (1 X TAE with either 0.02 µL EtBr/mL) or none with Midori 
Green, whereas about 1 µL Midori Green was applied directly into the 
chamber prior to electrophoresis.  
For analytical setups, 1 to 5 µL sample were mixed with ddH2O and 6 x 
MassRuler® DNA Loading Dye (Fermentas, R0621) or 6 x self made 
loading dye (2.5 ng/mL Bromphenol blue, 33 % [v/v] glycerol) to a total 
loading volume of 6 µL. For preparative applications, after restriction 
digestion, the complete 50 µL mix was mixed with 13 µL 6 x Loading Dye 
and applied to the gel. 
Electrophoresis was performed in running buffer at 130 V (analytical 
setup) or 90 V (preparative setup). The gel was illuminated for visualizing 
DNA bands (BioRad Gel Doc™) and DNA fragments for preparative usage 
were cut out and purified with gel extraction kit (mi-GE100, metabion), 
following the manufacturer’s instructions. DNA was eluted in 40 µL 1mM 
Tris/HCl pH 8, or sterile ddH2O. 
 
4.10 Analysis of (recombinant) proteins  
4.10.1 SDS-PAGE  
For protein gel analysis the NuPAGE® Novex® Bis-Tris system was 
used. 15 μL sample, 4 x LDS loading dye (NP0007) and 2 μL Reducing 
Agent (NP0004) were cooked at 99°C and 15 μL were loaded per slot. 
Dependent on the subsequent visualization of proteins, several different 
standards were used. For silver stain, we used 5 μL of 1:10 diluted Bench 
Mark™, for Western blot we either used 5 μL or 2 μL (dependent on 
secondary antibody) MagicMark™ Standard (for chemiluminescence 
detection, Figure 10/B) or 5 μL PageRuler™ Prestained Protein Standard 
for colorimetric detection (Figure 10/C). 
12 % Bis-Tris or 4-12 % Bis-Tris (especially for HSA analysis) gels with 
MOPS (NP0001) running buffer were used (Weber & Osborn, 1969). Inner 
and outer chamber (XCell SecureLock, Invitrogen) were filled with 1 x 
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MOPS and electrophoresis was performed at 180 V for approximately one 
hour. 
 
 
 
4.10.2 Silver Stain 
Silver staining is a very fast, sensitive and unspecific visualization 
method for protein stains (Rabilloud, 1999). Therefore, it was mainly used to 
determine secreted proteins in P. pastoris culture supernatant. 
After successful electrophoresis, the gels were incubated in fixing 
solution (per liter: 714 mL 70 % ethanol, 100 mL acetic acid) either for 1 h or 
overnight, followed by incubation for 1 h in incubation solution (per liter: 429 
mL 70 % ethanol, 68.2 g sodium acetate, 3.2 g Na2S2O3*5H2O; per 50 mL 
ad 125 μL gluteraldehyde). The gels were washed three times with ddH2O 
for 10 min and then 25 mL silver solution (per liter: 0.5 g AgNO3) with 5 μL 
37 % formaldehyde were used per gel. After incubation of 20 min the silver 
solution was removed, the gel washed with ddH2O and 25 mL development 
solution (250 mM Na2CO3) plus 2.5 μL gluteraldehyde were added per gel 
until an appropriate staining was visible. Then, gels were washed with 25 
mL stopping solution (0.5 M EDTA) and scanned for documentation (600 
dpi, Epson Scan). 
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4.10.3 Western blot 
For intracellular as well as extracellular visualization of specific proteins, 
Western blot analysis was performed. After gel electrophoresis, transfer 
buffer was prepared (per liter: 50 mL NuPAGE® 20 x Transfer Buffer, 100 
mL MeOH, 1 mL Antioxidant for reduced samples (NP0005); 250 mL per 
blotting chamber), in which sponges and filter paper (Whatman® 3mm Chr) 
were soaked. The nitrocellulose membrane (BioRad Trans-Blot® pure 
nitrocellulose membrane 0.2 μm) was applied upon the gel, according to the 
manufacturer’s instructions, and the blotting chamber was filled with 
Transfer Buffer. Blotting was mediated at 50 V for one hour in XCell 
SureLock® Mini-Cell Blot Module (Invitrogen). 
Thereafter, the membrane was blocked with 25 mL blocking solution (1 
x PBS, 0.1 % [v/v] Tween 20, 1 % [w/v] skim milk) for one hour, washed 
three times for 10 min with PBST. Incubation with primary antibody (dilution 
according to Table 4.10.5.1) in 7 to 10 mL blocking solution for one hour or 
overnight followed. After washing three times for 10 min with PBST, 
incubation with secondary antibody (dilution according to Table 4.10.5.2) 
and another washing step followed. 
 
4.10.4 Dot blot 
A dot blot was performed to distinguish the pTRP-binding ability of three 
different primary antibodies. Therefore, on four pieces of nitrocellulose 
membrane, 15 μL supernatant of P. pastoris, producing human trypsinogen 
and porcine trypsinogen as well as wild type supernatant, were spotted. The 
membranes were blocked with blocking solution for one hour, primary 
antibodies were diluted according to Table 4.10.5.1, Table 4.10.5.2 and 
Figure 19, washed again, incubated with secondary antibodies, washed 
again and incubated with AP Development Buffer until staining was visible. 
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4.10.5 Antibodies 
Antibodies were used and diluted according to Table 4.10.5.1 and Table 
4.10.5.2 in blocking solution. 
 
4.10.5. 1: Primary antibodies and specificity 
AB 
Target Host 
Monoclonal/ 
Polyclonal Dilution 
Product 
Name/Supplier Additional notes 
rpTRP Mouse whole serum 1: 75 SH22072010 
Immunization by Silvia 
Heiss 
rpTRP Mouse whole blood 1: 100 Polymun 
Immunization by 
Polymun 
rhTRP Rabbit polyclonal 1: 2,000 or 1: 100 
Acris; 
AP00906PU-N 
 
rpTRP Mouse whole serum 1: 100 or 1: 10 Polymun 
pTRP produced in P. 
pastoris 
HSA goat polyclonal 
1: 50,000 (WB) or 
1: 30,000 (ELISA) 
Bethyl; A80-
129P HRP conjugated 
eGFP Rabbit whole serum 1: 5,000 Abcam; ab290 
  
4.10.5. 2: Secondary antibodies and conjugates 
Antibody 
Target Host Dilution Reactivity 
Product Name/ 
Supplier Conjugate 
Rabbit 
IgG 
Goat polyclonal; IgG 
fraction antiserum 1: 10,000 
IgG whole 
molecule 
Sigma; 
A8275-1ML HRP 
Rabbit 
IgG 
Goat polyclonal; 
affinity isolated 
1:16,000 to 
1:160,000 
IgG whole 
molecule 
Sigma; 
A0545 HRP 
Mouse 
IgG 
Goat polyclonal; 
affinity isolated 1: 10,000 
gamma-chain 
specific 
Sigma; 
A3673 HRP 
Mouse 
IgG 
Goat polyclonal; 
affinity isolated 1: 80,000 Fab-specific 
Sigma; 
A2179 AP 
Mouse 
IgG 
Goat polyclonal; 
affinity isolated 1: 30,000 
gamma-chain 
specific 
Sigma; 
A3438 AP 
 
 
4.10.6 Conjugates and development of Western blot 
For antibodies linked to Alkaline Phosphatase (AP), development buffer 
for colorimetric detection was prepared (per 50 mL: 2 mL 25 x AP Color 
Development Buffer (BioRad), 500 μL Solution A and 500 μL Solution B). 
Per membrane, 25 mL were used and incubated at RT until bands were 
visible. For antibodies linked to horse radish peroxidase (HRP), 
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development buffer for chemiluminescect detection was prepared (per 
membrane: 2 mL Solution A, 2 mL Solution B; Thermo Scientific, Super 
Signal West Chemiluminescent Substrate), and after 5 min incubation time, 
chemiluminescence was detected at the LumiImager™ (Böhringer 
Mannheim; software Lumina32). 
 
4.10.7 Stripping 
For testing a different set of antibodies, stripping was performed. 
Previously bound antibodies were removed by incubating a membrane with 
25 mL stripping solution (per liter: 50 mM glycin, 1 mM EDTA at pH 2.3) for 
1 h at RT, followed by washing three times for 10 min with PBST and further 
incubation with 25 mL blocking solution. Subsequent steps followed as 
described above. 
 
4.11 Antibody production in mice 
Due to the fact that none of the tested antibodies were useful to detect 
pTRP, we decided to produce an antibody for pTRP in mice ourselves.  
Therefore, 4 mice (female, B6D2F1/Crl) were immunized with 25 μg 
porcine trypsinogen/mouse and injection. Right before immunization, 
approximately 400 μL blood per mouse (pre-bleed) was collected and 
merged as negative control for ELISA titer determination (Figure 11).  
Trypsin from porcine pancreas (Sigma-Aldrich, T0303-1G) was 
solubilized in 10 ml sterile 1 x PBS and diluted to 1 mg/ 2 mL with sterile 1 x 
PBS prior to immunization, mixed with 2 mL Freund’s Adjuvant Incomplete 
(Sigma-Aldrich, F5506) and shaken for at least 15 min at high-speed. After 
spinning down, 200 μL were injected per mouse, three times at an interval 
of three to four weeks. After the second boost, the antibody titer was 
determined by ELISA. 
 
4.12 Antibody titer determination 
For that reason, a Nunc-Immuno™ 96-well plate MaxiSorp™ (449824) 
was coated with 1 μg/mL (100 μL) porcine trypsinogen (T0303-1G; 100 
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mg/mL in 1 x PBS) in coating buffer (HSA carbonate buffer pH 9.6; 0.05 M 
carbonate-bicarbonate) over night. The next day, coating buffer was 
removed, the plate was washed three times with 1 x PBS with 0.1 %(v/v) 
Tween20 and 150 μL blocking buffer (1 x PBS, 1 % [w/v] BSA) were added 
to each well and incubated for 3 h at RT.  
After another washing step, 50 μL serum samples (pre-bleed and after 
immunization) were applied at an initial dilution of 1:10 in blocking buffer, 
further diluted in 1:2 steps on the plate and incubated over night at 4°C. 
Initial dilution was set very low, because we were not sure if immunization 
with an antigen, such as porcine trypsinogen which differs only marginally 
from a host protein, would stimulate mouse immune response sufficiently. 
After washing three times, 50 μL detection antibody (1: 500 in blocking 
solution; goat-α-mouse IgG, HRP linked, A3673) were added to each well 
and incubated for 3 h. Development of enzymatic color reaction was 
mediated with OPD (P9187). Therefore, 50 μL development buffer was 
added (200 μL OPD solution (one tablet in 20 mL ddH2O), 16 μL 30 % H2O2 
in 20 mL citrate buffer; pH 4.7) to each well and after approximately one 
minute, the reaction was stopped with 50 μL 3 M H2SO4. 
The plate was read at 450 nm, the blank (solely blocking buffer) was 
subtracted, and it was taken account to the dilution factor within each well. 
The antibody concentration obviously could not be determined, but we could 
clearly distinguish between pre-bleed and serum samples after 
immunization (Figure 11).  
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Subsequently, the immunization experiment with mice was stopped and 
the remaining blood was collected, merged and centrifuged for 5 min at 4 
rpm after clotting. The serum (SH22072010) was then used for Western blot 
analysis of intracellular and secreted pTRP. 
 
4.13 Trypsin activity assay 
Secreted porcine trypsinogen was further determined and measured by 
means of TAME-assay (Walsh and Wilcox, 1970), where trypsin activity is 
based on its esterase activity to TAME (p-toluensulfonyl-L-arginin methyl 
ester HCL; Sigma, T-4626), and the increase of absorption at 247 nm was 
measured over time. 
Photometric detection was mediated with HITACHI U-2910 double 
beam spectrophotometer in UV-plastic cuvettes (Brand 7592 00), UV-
solutions software and Krüss PT-31 electronic thermostat with Peltier-
element. 
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4.13.1 Buffer exchange 
The salt amount and turbidity in the culture medium is debilitating for 
activity measurement. Therefore, supernatants were desalted by buffer 
change, using PD-10 small size-exclusion desalting columns (GE 
Healthcare). Together with LabMate Buffer Reservoir, a volume up to 25 mL 
could be loaded onto one column. 
Prior to purification, PD-10 columns were equilibrated with 25 mL 1 mM 
HCl (5 x column volume). Thereafter, 2.5 mL well mixed supernatant was 
applied. Elution of proteins into fresh tubes with 3.5 mL 1 mM HCl followed 
and 70 µL 2 M CaCl2 was added to each tube for stabilizing trypsinogen and 
retarding self digestion (autoproteolysis). Samples were either measured 
right after or stored at -20°C until analysis. 
 
4.13.2 Activity measurement 
Trypsinogen was activated to trypsin through enterokinase (lyophilized, 
Sigma E5510/E0632). By cleaving off the N-terminal hexa-peptide the 
thereafter active trypsin catalyzes the hydrolysis of p-toluensulfonyl-L-
arginine methyl ester HCL by proteolytic cleaving on the C-terminal side of 
arginine.  
Activation buffer (per liter: 6.1 g Tris base, 5.9 g CaCl2*H2O at pH 8.6) 
and dilution buffer (per liter: 4.9 g Tris base, 5.9 g CaCl2*H2O at pH 8.1) 
were prepared and stored at RT for up to one month. For activating 
trypsinogen at pH 8.6, 300 µL sample, as well as one negative control (300 
µL 1 mM HCl), were incubated for 2 h at 37°C with 690 µL freshly prepared 
enterokinase solution (63.8 U/ml activation buffer).  
 
As samples were measured at 30°C, the PT-31 was checked and the 6-
cell changing chamber was attached to the thermostat. TAME solution was 
freshly prepared (1.18 mM; 22.3 mg TAME in 50 mL dilution buffer) and 1 
mL were applied to each cuvette. For activity measurement of samples, 165 
µL sample or 165 µL dilution buffer (blank) were added to 1 mL TAME 
solution, mixed and measurement started immediately for 5 min. With the 6-
cell changing chamber, 6 samples could be measured at once, where the 
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extinction change is measured (15 s per cell) giving a linear slope 
(ΔE247/min) which should not exceed 0.06. Values up to ΔE247= 0.30 are 
directly proportional to the trypsinogen amount. Otherwise samples need to 
be diluted. Trypsin amount (µg/mL) was calculated according to equation 3. 
As reported elsewhere (Vandermeers, 1972), the benefit of a high 
TAME concentration is that the assays are more sensitive and that the 
velocity of the reaction remains constant throughout most of the TAME 
hydrolysis. Maximal velocities for trypsin catalyzed hydrolysis are obtained 
at a pH of about 8.  
 
Equation 3: Calculating µg trypsin per mL on the basis of extinction change 
 
         
  
      
                 
 
 
 
ΔΕ247 extinction at 247 nm per minute 
DF dilution factor in enterokinase activation solution (1:20) 
F dilution factor due to buffer change and CaCl2 addition  
 (3.57 mL/2.5 mL) 
ϵ specific extinction coefficient ϵ = 0.0101 E247 cm
-1 min-1 
 
4.14 N-terminal protein sequencing 
Edman-degradation was used to determine the N-terminal amino acids 
of an unknown secreted protein band (Figure 21). Therefore, 500 µL of 
respective supernatant was loaded onto a centrifugal filter for concentrating 
the protein (Amicon Ultra-0.5 mL 10 kDa centrifugal filter, Millipore, 
UFC5010), centrifuged for 5 min and 15 µL sample were recovered by 
reverse spin. 
Thereafter, samples were prepared as described before, applied onto a 
4-12 % Bis-Tris NuPAGE®. Western blot with borate buffer (per liter: 3.09 g 
Borate [50 mM], 100 mL MeOH at pH 9 set with 1 M NaOH) was performed 
for 2 h at 25 V but using a PVDF (polyvinylidene fluoride) membrane 
instead. Prior to blotting, the gel was incubated in borate buffer for 10 min, 
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whereas the membrane was dipped into methanol for 30 s followed by 3 min 
in borate buffer. 
After blotting, the membrane was stained for 3 min with Coomassie (0.1 
% [w/v] R250, MeOH [40 % v/v], acetic acid [10 % v/v]), followed by 
destaining (MeOH [40 % v/v], acetic acid [10 % v/v]). The membrane was 
rinsed with ddH2O and the protein band of interest was cut out and sent to 
A. Univ.-Prof. Dr. Herbert Lindner (Medical University Innsbruck) for N-
terminal sequencing. 
 
4.15 HSA- ELISA (enzyme-linked immunosorbent assay) 
For quantitative detection of human serum albumin, the enzyme-linked 
immunosorbent assay using the Human Albumin ELISA Quantitation Set 
(Bethyl, E80-129) were the method of choice.  
Therefore, the coating antibody (A80-129A; Bethyl) was diluted to a 
concentration of 1 µg/mL (1: 1,000) in coating buffer (0.05 M carbonate-
bicarbonate, pH 9.6). Therefrom, 100 µL were transfer to each well of a 
MaxiSorp™ 96-well plate (Nunc, 442404) and incubated for 1 h or over 
night at RT on a rotary shaker. Afterwards, each well was washed with 200 
µL wash buffer (50 mM Tris, 0.14 M NaCl, 0.05 % [v/v] Tween20 at pH 8.0). 
Aspiration and washing was repeated four times with TECAN 96-well 
microplate wash station. 
Subsequently, 200 µL blocking buffer (50 mM Tris, 0.14 M NaCl, 1 % 
[w/v] BSA at pH 8) were added to each well and incubated for 30 min at RT 
on a rotary shaker. Washing of each well was performed as described 
above. 
Samples were diluted in dilution buffer (50 mM Tris, 0.14 M NaCl, 1 % 
[w/v] BSA, 0.05 % [v/v] Tween20 at pH 8.0) based on expected 
concentration of HSA in the samples. Necessarily, sample concentration 
has to be within the concentration range of the standard. To one row dilution 
buffer only was applied (blank). The standard (stock of 25 mg/mL; Bethyl, 
RS10-110) was diluted, to an initial concentration of 500 ng/mL was applied 
twice. 200 µL of standard and sample were transferred to the first assigned 
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wells and diluted 1:2 in dilution buffer in the following rows and incubated for 
1 h at RT on a rotary shaker. Washing was performed as described above. 
Detection antibody (anti-HSA, HRP-conjugated; Bethyl, A80-129P) was 
diluted 1:30,000 in dilution buffer, 100 µL were transferred to each well and 
incubated for 1 h at RT on a rotary shaker, followed by a washing step.  
For HRP mediated enzymatic conversion of peroxidase substrate TMB 
(3,3’,5,5’-tetramethylbenzidine, Bethyl, E102), 100 µL of 1:2 mixed substrate 
and Peroxidase Solution B were added to each well. For enzymatic 
reaction, plates were incubated for 15 min in the dark at RT. The incubation 
time of TMB substrate depends on the intensity of color development, which 
is direct proportional to the concentration of HSA in the samples. The 
highest standard concentration should have an OD450 of 2.0 – 2.5, whereas 
the lowest standard concentration should slightly exceed the blank. 
The reaction was stopped by applying 50 µL of 2 M H2SO4 to each well. 
The color intensity was measured with a microplate reader (Infinite® 200 
Pro, TECAN). Data analysis was performed using Magellan™ software.  
The average blank value was subtracted from the average absorbance 
values. A standard curve was made using software that generates a four 
parameter logistic (4-PL) curve-fit. The calculated HSA concentration of 
samples and standard was calculated by using the standard curve. 
Obtained concentrations were multiplied by the dilution factor to determine 
the concentration of undiluted samples. 
 
4.16 Cell disruption for intracellular protein analysis 
Three different methods for receiving intracellular protein were used. 
They all had in common that the pellet of 1 mL culture was resuspended in 
the respective lysis buffer and transferred to ribolyzer tubes. 0.5 mL glass 
beads (Ø 0.3 mm) were added and cell disruption was performed by using 
MP-Fast Prep 24 at level 6 for 3x 20 s. Three different methods were used 
as result of simplifying the application. 
The method used first implicated the addition of 50 mM Tris/HCl (pH 
7.4), 300 mM NaCl, 5 mM EDTA and 0.02 % (w/v) sodium azide and 
Protease Inhibitor Cocktail (Sigma, P2714) to 1 x PBS and 1 % (v/v) 
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TritonX-100. The lysate was transferred by pipetting into a 1.5 mL 
Eppendorf tube and centrifuged for 15 min at full speed. The supernatant 
was applied to a new tube and used for analysis.  
The second method implied the use of only 1 x PBS with 1 % (v/v) 
TritonX-100 and a Protease Inhibitor Tablet (Sigma, S8820-20Tab). After 
mechanical cell disruption, the tubes were put at 99°C for 10 min for 
denaturation. Further, a small hole was prepared at the bottom of the 
ribolyzer tube and then transferred on top of a 1.5 mL Eppendorf tube. 
Through centrifugation at 1.6 rpm for 2 min, the liquid phase without cell 
debris was collected and used for analysis. 
The third method only differed in the last steps. Here, after mechanical 
cell disruption, the lysate was collected following the method described 
above. Therefrom, 150 µL were mixed with 50 µL LDS loading dye, put at 
99°C for 10 min and centrifuged for 1 min at 13.2 rpm The addition of LDS 
stabilizes denatured proteins. The supernatant was collected and was 
directly applied to NuPAGE® gels. 
 
4.17 Flow cytometry measurement (FCM) of eGFP fluorescence 
Promoter strength of PGAP and PEPX was analyzed by the expression of 
eGFP which was determined by FCM. Subsequently, 5 µL culture was 
mixed with 1 mL sterile particle free 1 x PBS and cell clots were separated 
by ultrasonic exposure (3 s, 45 % pulser duty, output control 3.5; vibracell 
Sonic & Materials). 
FACS Calibur (BD biosciences), equipped with a 488nm excitation 15 
mW air-cooled argon-ion laser and a 630 nm diode laser, was prepared for 
analysis and FCS Express software was started. Gates were set to exclude 
cell debris and forward scatter (FSC) and side scatter (SSC) were 
measured. FSC geo mean and fluorescence emission signal (FL1) geo 
mean (of 10,000 cells per sample) measurement followed by using PBS as 
sheat fluid. The FL1 signal was gained in a logarithmic mode by using a 
530/30 band-pass filter. Relative eGFP expression levels related to cell 
volume were calculated as described by Hohenblum (Hohenblum, Borth & 
Mattanovich, 2003). The untransformed wild type was used as blank. 
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4.18 Fluorescence photometry 
Cell pellets of 1 mL culture were collected by centrifugation (2 min, 13.2 
rpm), washed and resuspended in 1 x PBS. Intracellular fluorescence was 
measured with a spectrofluorimeter (excitation 490 nm; emission 510 nm, 
25°C). Measured values were normalized for the intrinsic fluorescence of 
control P. pastoris cells. 
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5 Results  
5.1 Extracellular protein X promoter (PEPX1) analysis 
To investigate the strength of PEPX1, 1,000 bp upstream of the Epx1 
start codon were amplified via PCR and used for experimental 
determination. Therefore, P. pastoris X-33 was transformed with plasmids 
expressing eGFP under the control of either PGAP or PEPX1, and integrated 
into the same locus (AOXTT) in order to rule out position effects. 
 
5.2 Expression analysis of eGFP under the control of PGAP and 
PEPX1 at three different carbon sources  
Approximately 12 clones of each construct were simultaneously 
screened in complex-screening-medium with glucose as carbon source and 
compared to the non-eGFP expressing wild type. Sampling was carried out 
after 24 h and 48 h for analyzing expression at different growth rates via 
FCM (flow cytometry measurement). Hence, promoter activity was 
measured indirectly by observing expressed gene product. 
Figure 12 shows mean eGFP fluorescence per cell size, obtained by 
averaging over two independent screenings. The number of clones was 
varying, hence some clones were measured twice and some only once. 
Generally, eGFP expression was enhanced after 48 h screening period, 
hence PGAP throve eGFP expression about 10-fold (A: 5.65*10
-3 mean 
fluorescence/cell size, SD: 2.68*10-3) compared to PEPX1 (A: 3.79*10
-4 mean 
fluorescence/cell size, SD: 2.77*10-4). Outliers may indicate multiple 
integrations (not verified). 
 
54 
 
 
 
As Epx1 has also been observed in methanol grown cells previously, 
promoter activity was also tested on other commonly used carbon sources, 
such as methanol and glycerol. In general, promoters are known to respond 
differently to varying carbon sources (Stadlmayr et al., 2010; Waterham et 
al., 1997). 
Therefore, PEPX1 and PGAP activity of approximately 12 clones was 
additionally analyzed in complex-screening-medium with glycerol (Figure 
13/A) and methanol (Figure 13/B) as carbon source and compared to the 
non-eGFP expressing wild type.  
After 48 h screening period, we observed that glycerol enhanced PGAP 
activity (A: 1.43*10-2 mean fluorescence/cell size, SD: 3.76*10-3), but had 
little positive effect on PEPX1 activity (A: 1.87*10
-3 mean fluorescence/cell 
size, SD: 1.28*10-3). Expression was up to 10-times higher compared to 
glucose, but PEPX1 was still significantly lower than PGAP (Figure 13/A). 
There was rather no increase of PEPX1 (A: 1.73*10
-4 mean fluorescence/cell 
size, SD: 8.99*10-5) and PGAP activity (A: 1.61*10
-3 mean fluorescence/cell 
size, SD: 1.11*10
-3
) by using methanol as carbon source (Figure 13/B). 
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5.3 Expression analysis of pTRP under the control of PGAP and 
PEPX1  
Additionally, porcine trypsinogen secretion (pTRP) was analyzed, under 
the control of PGAP and PEPX1. As pTRP is secreted, we also evaluated the 
use of the extracellular protein X secretion leader prepro-sequence 
(Epx1pp) and compared it to the MFα1pp. The four therefore constructed 
plasmids were integrated into the P. pastoris PGAP or the PEPX1 native 
promoter locus, respectively. 
To monitor pTRP secretion, influenced by leader or promoter, 12 
individual clones of each construct were incubated in YPD-Zeocin™ 
preculture plus the wild type as control in YPD without Zeocin™, and 
simultaneous shake-flask-cultivation for 48 h in complex-screening-medium 
was performed. Sampling occurred only once after 48 h as no growth rate 
dependency in expression level was observed during FCM analysis. Figure 
14 shows measured trypsinogen in the cultivation supernatant, obtained by 
averaging over two independent screenings of identical clones. 
Porcine trypsinogen (pTRP) secretion was quantified via TAME-assay 
(activity analysis) and protein quality was examined via SDS-PAGE (silver 
stain). Similarly to eGFP expression determined by FCM, promoter strength 
was indirectly measured through trypsin activity. In accordance to the 
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previously obtained results, PEPX1 did not lead to high levels of secreted 
pTRP (with Epx1pp, A: 2.341 µg trypsinogen/g wcw, rel. SD: 95 %; with 
MFα1pp, A: 2.553 µg trypsinogen/g wcw, rel. SD: 224 %).  
In contrast, PGAP with MFα1pp as secretion leader on average led to 
76.2 µg/g trypsinogen per wet cell weight (rel. SD: 17 %), compared to 
41.15 µg/g trypsinogen per wcw (rel. SD: 34 %) with Epx1 secretion leader 
(Figure 14). Apparently, Figure 16/A again shows differences in promoter 
strength of PGAP and PEPX1, analyzed via silver staining. Lanes 3 to 7 as well 
as 10 to 14 show extracellular pTRP, expressed under the control of PEPX1. 
In comparison to lanes 8 and 15, pTRP secretion under the control of PGAP 
was significantly stronger. 
 
 
 
These results clearly indicated that high expression and secretion of 
extracellular protein X, might not be due to its promoter. However, pTRP 
secretion seems to be efficiently driven by using the Epx1 secretion leader. 
Therefore, we analyzed the secretion leader of Epx1 concerning its ability to 
enhance recombinant protein production. 
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5.4 Extracellular protein X secretion leader (Epx1pp) analysis  
Secretion leaders do have significant impact on secretion efficiency in 
yeast (Sreekrishna et al., 1997). They share similar motifs (positively 
charged N-terminus, followed by a hydrophobic middle sequence and a 
polar C-terminus) which also Epx1pp shows. For example, we confirmed the 
hydrophobic Epx1 pre-sequence by hydropathicity analysis using Kyte and 
Doolittle algorithm (Kyte & Doolittle, 1982) with a window size of 9 (Figure 
15) by using ExPASy Proteomics Server 
(http://expasy.org/tools/protscale.html). The dibasic motif within the pro-
sequence is indicated, but discussed later. 
The pre-sequence determines either co-translational or post-
translational transport into the ER with or without SRP-dependency; 
embedded within the hydropathicity of the pre-sequence. According to Ng 
and co-workers (Ng et al., 1996), the Kyte and Doolittle blot indicates that 
most likely Epx1pp is SRP- independently targeted to the ER (Figure 15).  
 
 
 
Epx1-pre sequence comprises 20 amino acids. Using SignalP platform, 
we determined signal peptidase cleavage site between position 20 and 21: 
VSA-AP (http://www.cbs.dtu.dk/services/SignalP/). The signal peptidase 
cleavage site is followed by three hydrophobic amino acids (Ala-Phe-Val), 
determining the start of the pro-region (Figure 15/A). The pro-region 
comprises 37 amino acids and Figure 15/B indicates its hydrophilic range. 
We determined the leader end by N-terminal sequencing of the purified, 
extracellular protein X, however an additional dibasic motif within the pro-
sequence was noticed, which indicated a possible Kex2 favored cleavage 
site, but was not further implicated at this time. 
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5.5 Comparative analysis of pTRP with native Epx1pp and 
MFα1pp secretion leader under the control of PGAP and PEPX1 
As already reported, the expression profile of pTRP was analyzed under 
the control of PGAP and PEPX1 (integrated into the Gap- or Epx1 promoter 
locus) for investigating promoter strength on the one hand and Epx1 leader 
analysis on the other hand, in comparison to the well studied and efficient 
MFα1pp. As discussed above (Figure 14) and additionally shown below, 
expression under the control of Epx1 promoter showed diminished levels 
(Figure 16/A, lane 3-7 and 10-14; Figure 14/B) compared to the Gap 
promoter (Figure 16/A, lane 8 and 15; Figure 14/A) comparing both leader 
sequences. Therefore, PEPX1 analysis was discontinued and we performed 
further studies under the control of PGAP.  
 
5.5.1 Qualitative analysis of pTRP secretion 
Unexpectedly, pTRP expression using the Epx1 secretion leader led to 
a protein smear of unidentified cause (Figure 16/A, and 16/B, black dot), 
whereas MFα1pp led to secreted pTRP of correct size (25 kDa; Figure B, 
arrow). Parts of secreted pTRP with Epx1pp, however, also led to correct 
size pTRP, albeit to a lesser extent. We hypothesized that the smeared 
band represents an Epx1pp-pTRP fusion protein, which appears due to 
incorrect processing, leading to partially unfolded pTRP. 
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We speculated whether this fusion protein (or just the small amount of 
correct size trypsinogen) could be activated by enterokinase or not. 
Diminished conversion of TAME then might not adequately represent the 
amount of secreted pTRP.  
 
5.5.2 Activation test of Epx1pp-pTRP fusion protein with enterokinase  
To test the capability of enterokinase in activating Epx1pp-trypsinogen 
fusion protein, two random clones per construct were analyzed. The 
supernatant before and after enterokinase incubation was visualized via 
reduced SDS-PAGE (Figure 17). Trypsinogen secreted by any leader, 
acquires zymogen activation to trypsin through enterokinase. A hexa-
peptide at the trypsinogen N-terminus is thereby cleaved off by releasing 
active trypsin (Table 5.7.1).  
Even though Epx1pp led to an aggregation of indeterminable cause, 
activation with enterokinase yielded correctly cleaved trypsin (Figure 17/lane 
2 and 3) and as expected, trypsinogen secreted by MFα1pp was fully 
activated too (Figure 17/lane 6 and 7). These results indicate that the 
secreted amount of trypsin measured with TAME assay likely corresponds 
to the actual secreted amount of pTRP.  
 
 
 
5.5.3 Analysis of intracellular pTRP  
As Epx1pp secreted trypsinogen, but shows significant amounts of 
Epx1pp-pTRP fusion-protein extracellularly, we speculated if we can also 
see effects intracellularly. Therefore, the cell pellet of several clones was 
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disrupted to obtain intracellular proteins and a Western blot was thereof 
performed. 
Surprisingly, neither the anti-hTRP (Figure 18/A) nor the anti-pTRP 
(Figure 18/B) antibody bound at expected size (~25 kDa). In contrast, 
unspecific binding of each antibody to high molecular mass proteins, 
independent of the used secretion leader was observed.  
 
 
 
The question arose whether no pTRP was within the cells, hence 
completely secreted or if the antibodies were not binding as expected. 
Therefore, a Dot blot was prepared (Figure 19) with samples of different 
supernatants, wherein trypsin was prior determined (not shown). 
Figure 19/A shows that rabbit-α-hTRP also binds pTRP, whereas 
mouse-α-pTRP antibody detects pTRP even at a dilution of 1:100 (Figure 
19/B and 19/C), and mouse whole blood also showed pTRP recognition 
(Figure 19/D). Unexpectedly, the same antibody, which detected secreted 
pTRP in this Dot blot (displayed in B and C) failed to bind intracellular pTRP 
specifically (Figure 18). 
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This antibody (α-pTRP, Figure 19/B and C) was created in mice but the 
antigen (pTRP) was produced in P. pastoris. We therefore assumed that on 
the one hand, it binds abundantly available pTRP in the supernatant, but on 
the other hand it binds unspecific yeast protein rather than small amounts of 
pTRP.  
Nonetheless, for subsequent visualization of intracellular pTRP an 
antibody was produced in mice. Therefore, mice were immunized with 
trypsin from porcine pancreas (Sigma-Aldrich, T0303-1G). After the second 
boost, the titer determination by ELISA (Figure 11) revealed sufficient anti-
pTRP antibody production (compared to pre-bleed). The sera were used for 
extra- and intracellular pTRP detection by Western blot. Unfortunately, the 
new antibody again detected secreted pTRP, but failed to detect small 
amounts of intracellular pTRP (data not shown).  
Moreover, once more unspecific band patterns were observed 
intracellelularly. Due to similar patterns received by other blots and mouse 
derived antisera within our group in the meantime, we reasoned that this 
pattern was due to unspecific binding of secondary antibodies.  
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5.5.4 Analysis of Epx1pp-pTRP fusion protein in accordance to 
altered pH-values and incubation time 
As described within the introduction, proteins related to Epx1 were 
identified to undergo autocatalytic activation and cleavage of pro-peptide; 
most likely mediated through an additional cleavage site within the pro-
sequence (Albrecht et al., 2006; Leduc R, 1992; Parr et al., 2007; Wilcox & 
Fuller, 1991). Furthermore, other proteins such as yapsins and aspartic 
proteases assist at the cell surface in processing at mono- or dibasic sites, 
however, most of them are cell wall anchored (Gagnon-Arsenault et al., 
2006). Notably, the secretome of P. pastoris was analyzed and no 
proteolytic enzymes were found outside of glucose grown cells (Mattanovich 
et al., 2009b). Cell free supernatant was analyzed, therefore membrane-
bound processing enzymes can still be assumed to cleave at specific 
motives shortly after secretion. 
Epx1 also has an auxiliary dibasic site within the pro-sequence (Figure 
15) and therefore, we tested whether the Epx1pp-pTRP fusion protein 
appearance changed after time in supernatants, also containing natively 
secreted Epx1. We reckoned if extracellular dimerized Epx1 is present, it 
may cleave the Epx1 pro-sequence attached to pTRP over time and altered 
pH values.  
Trypsin is a serine protease, cleaving peptides C-terminal of Lys or Arg. 
We also supposed the possibility of active trypsin itself cleaving at the 
Epx1pro Lys-Arg sequence of unprocessed Epx1pp. Another characteristic 
of trypsin is its optimal operating pH of about 8. Screening medium in 
contrast has a buffered pH of about 4 at the end of the screening. The pH 
was set from 4 to 6 to observe differences, but not to enhance its 
autocatalytic properties. The supernatant per clone was incubated at three 
different pH values for 76 h at 30°C with sampling every 24 hours (Figure 
20). 
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No distinctive difference or degradation of Epx1pp-pTRP fusion-protein 
through native secreted Epx1, in accordance to pH value of complex-
screening-medium or incubation time was observed for any construct. The 
suggested impact of proteolytically active trypsin to the protein smear as 
well as the possibility of extracellular protein x cleaving the Epx1pp pro-
sequence therefore was rejected.  
 
5.6 Qualitative analysis of HSA, secreted with native Epx1 and 
native HSA secretion leader 
Human serum albumin (HSA) is a globular monomeric protein which 
possesses no enzymatic activity and was often successfully secreted by its 
native signal leader in the P. pastoris expression system (Kobayashi, 2006). 
Therefore, HSA in combination with its leader sequence was used for 
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comparison; the expression vector was obtained by G. Stadlmayr 
(Stadlmayr et al., 2010). Additionally, Epx1pp was studied as alternative 
secretion leader for HSA, and was amplified via PCR with respective C-
terminal Epx1pp overhangs and replaced pTRP in the previously used 
vector.  
 
12 individual clones of each construct 
were analyzed concerning secretion 
behavior after 48 h shake-flask cultivation in 
synthetic screening medium. Qualitatively, 
secreted HSA was examined by reduced 
SDS-PAGE and visualization by using silver 
stain. Apparently, the expression pattern 
with the Epx1pp variants was different than 
observed with pTRP. Once again, an 
Epx1pp-fusion protein by expression with 
the native Epx1 leader was observed, 
hence no smear, but a distinct double band 
appeared (Figure 21, lane 2 and 3). In 
comparison with HSA secreted by its native leader and purified HSA 
(positive control, Figure 25/B) we concluded that the lower band was 
correctly processed HSA. The upper band was unexpected, but due to its 
slightly bigger molecular weight, we presumed that the Epx1 pro-sequence 
was partially cleaved at the dibasic site (Lys-Arg).  
 
Therefore, the supernatant of one random clone was used to prepare a 
Western blot. The upper and lower bands were cut out and sent for N-
terminal sequencing. Our presumption concerning cleavage after the dibasic 
Lys-Arg motive, instead of the monobasic Arg-Thr predicted end, was 
verified by N-terminal sequencing. For the upper band, AYYT was 
determined N-terminally, and for the lower band, D was determined N-
terminally as the first amino acid, conclusively with the first amino acid of 
HSA (Table 5.7.1). Hence, we obtained HSA with 21 amino acid overhang 
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by remaining Epx1 pro-sequence (Figure 21, upper band) in addition to the 
correctly cleaved form (lower band). 
 
5.7 Generating a shortened Epx1 secretion leader sequence by 
omitting amino acids of Epx1 pro-sequence 
The presumption arose that the Lys-Arg motif within the pro-sequence 
somehow disturbs correct processing. Numerous proteins which might be 
Kex2p target proteins have been annotated and analyzed by Bader and 
colleagues. In short, Kex2p substrate recognition and specificity varies 
between yeasts. These authors also depicted that Kex2p processing 
additionally depends on three-dimensional structure and species/protein 
related specifications (Bader et al., 2008). 
We reckoned if omission of 21 amino acids at the C-terminal pro-
sequence and 
the therefrom 
resulting 
dibasic leader 
end (Figure 
22) will favor 
and enhance 
correct 
processing, in 
particular by Kex2p. The shortened Epx1 leader (Epx1pp-KR) was therefore 
amplified via PCR and its impact on secretion of pTRP, HSA and eGFP was 
analyzed.  
 
Table 5.7.1 gives an overview concerning recombinant proteins used in 
this study. It lists the first 15 N-terminal amino acid sequences of porcine 
trypsinogen (with hexapeptide; underlined; chipped off for receiving active 
trypsin), human serum albumin (with native HSA secretion leader; positive 
control; underlined), and enhanced green fluorescent protein (with alpha 
mating factor leader and spacer peptide; positive control; underlined). 
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5.7. 1: Amino acid sequences of recombinant proteins used in this study 
Accessory sequence and recombinant protein 15 N-terminal amino 
acids 
hexapeptide + 
porcine trypsin  
 TDDDDKIVGGYTCAA 
native HSA leader 
+ HSA  
MKWVTFISLLFLFSSAYSRGVFRR DAHKSEVAHRFKDLG 
MFα1pp (incl. 
spacer peptide) + 
eGFP  
MRFPSIFTAVLFAASSALAAPVNT
TTEDETAQIPAEAVIGYSDLEGDF
DVAVLPFSNSTNNGLLFINTTIASI
AAKEEGVSLEKREAEAEF 
VSKGEELFTGVVPIL 
 
 
5.7.1 Shortened Epx1pp (Epx1pp-KR) and the impact on pTRP 
secretion 
Simultaneously, a population of approximately 12 individual clones for 
each construct was screened. Therefore, the same previously screened 
clones were compared with 12 clones employing the shortened Epx1 leader 
(Epx1pp-KR).  
First, supernatants were analyzed after 48 h shake-flask cultivation in 
synthetic-screening-medium via SDS-PAGE and silver staining. We 
surprisingly observed that processing was indeed enhanced by using the 
shortened Epx1 secretion leader (Figure 23, lane 6 to 9). Moreover, no 
protein smear or the like was detected. 
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Secondly, the expression mediated by the shortened leader in 
comparison to native Epx1pp and MFα1pp was quantitatively analyzed. The 
same clones for native Epx1pp-pTRP and MFα1pp-pTRP were used as in 
Figure 14/A. Expression was generally augmented due to using synthetic-
screening-medium in contrast to complex-screening medium, hence the 
same clones showed marginal expression differences between the two 
screenings. However, the distribution remained similar.  
Clearly, the shortened Epx1 secretion leader enhanced protein 
expression (Figure 24), yielding approximately 100 µg correctly processed 
trypsinogen per gram wet cell weight. 
 
 
5.7.2 Shortened Epx1pp (Epx1pp-KR) and the impact on HSA 
secretion 
A population of 12 individual clones from each construct was 
simultaneously screened in shake-flask cultivation with screening medium 
for 48 h and the supernatant was analyzed via Western blot (Figure 25/A) 
and silver stain (Figure 25/B).  
As reported previously, native Epx1 secretion leader led to a double 
band when secreting HSA. We approved that the Epx1 pro-sequence was 
partially cleaved at the intrinsic Lys-Arg sequence. Therefore it was 
assumed, that omitting the subsequent 21 amino acids would facilitate 
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secretion leader processing, thus leading to improved secretion of HSA. In 
contrast, the shortened leader failed to augment secretion of HSA, even 
though HSA was processed correctly (Figure 25/A and 25/B, lane 6 to 9). 
 
 
 
Additionally, secreted HSA was quantitatively analyzed via HSA-ELISA. 
At a dilution of 1:50, supernatants of 9 (respectively 6 for HSA) clones were 
analyzed (Figure 26). In accordance to reduced SDS-PAGE analysis, the 
shortened Epx1pp averaged 1.3 mg/L HSA, whereas the native Exp1pp 
yielded 6.3 mg/L HSA which was significantly lower (p < 0.05) than native 
HSA leader (13.1 mg/L). 
 
 
5.7.3 Comparative analysis of intracellular HSA with native and 
shortened Epx1pp, and native HSA leader 
Intracellular determination of HSA by Western blot revealed a different 
band pattern as expected regarding to extracellular HSA, even though 
performed several times, comparing different screenings and using different 
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methods for intracellular protein analysis (Figure 27). However, intracellular 
and extracellular expression level matched. Interestingly, no intracellular 
double band pattern was seen for native Epx1pp. HSA levels with the 
shortened Epx1pp secretion leader were very weak intracellularly (Figure 
27, lane 6 to 9); indicating a bottleneck in leader processing. 
 
 
 
Immunofluorescence analysis of intracellular HSA performed by Verena 
Puxbaum, however, achieved visualization of clear differences within the 
cellular distribution (Figure 28). The native Epx1pp led to distribution of HSA 
at the plasma membrane and the bud (Figure 28/A.1). Plasma membrane 
staining was already reported for hydroxynitrile lyase in S. cerevisiae 
(Hasslacher et al., 1997), where it indicated periplasmatic retention, while 
bud staining usually is a sign for secretion. The shortened leader in contrast 
showed disposition into the cytosol (Figure 28/B.1), and the native HSA 
leader illustrated a weak staining, probably of the ER/nuclear envelope 
(Figure 28/C.1).  
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It seemed that the expressed HSA is transported more or less efficiently 
out of the cells by native Epx1pp and HSA leader. In contrast, the shortened 
leader showed weak expression at extracellular and intracellular analysis. 
Therefore, the cytosolic localization of HSA determined by IF rather 
displayed folding and processing difficulties, which may lead to ERAD, and 
furthermore ubiquitin mediated degradation of HSA within the cytosol. 
 
5.7.4 Comparative analysis of secreted eGFP with native and 
shortened Epx1pp, and MFα1pp secretion leader 
Additionally enhanced green fluorescent protein (eGFP) was tested 
concerning its secretory behavior, triggered by native Epx1pp, shortened 
Epx1pp and MFα1pp as control (expression vector described in Stadlmayr 
et al., 2010). For achieving the two different Epx1pp constructs, eGFP with 
respective C-terminal Epx1pp overhangs was amplified by PCR and 
replaced HSA in the previously used vector. 
Green fluorescent protein has been studied and exploited extensively in 
biochemistry and cell biology since its development in the 1960s. The 
advantage of GFP’s in vivo detection makes it a powerful tool for protein 
localization analysis. Several studies in yeasts concerning secretion of GFP 
and GFP-fusion proteins were however deflating, as many secretion signals 
failed to secrete eGFP in S. cerevisiae (Li et al., 2002). In P. pastoris, the 
K28pptox was reported to allow eGFP secretion (under control of PAOX1) 
(Eiden-Plach et al., 2004) as well as the PHA-E signal peptide (Raemaekers 
et al., 1999); showing no N-terminal extension compared to MFα1pp 
(Campbell & Choy, 2002). Additionally, eGFP-lipase fusion protein was 
secreted efficiently under the MFα1pp signal leader, approximately similar 
to wild type lipase (Passolunghi et al., 2003).  
A population of 12 individual clones of each of the three constructs was 
simultaneously screened in shake-flasks with synthetic-screening-medium 
for 48 h. The reduced supernatants were analyzed via Western blot (Figure 
29/A) and silver stain (Figure 29/B). Apparently, native Epx1pp failed to 
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secrete eGFP completely (Figure 29, lane 2 to 5), in contrast to Epx1pp-KR 
and MFα1pp. 
Interestingly, only the Epx1pp-KR leader led to correct size eGFP 
(Figure 29, lane 6 to 9), whereas leftovers of MFα1pp leader led to higher 
molecular weight eGFP (Figure 29, lane 10 to 13). This was a well-known 
effect due to remaining (EA)2 overhang of spacer peptide. 
 
 
 
5.7.5 Comparative analysis of intracellular eGFP with native and 
shortened Epx1pp, and MFα1pp secretion leader 
Intracellular analysis of eGFP via Western blot (Figure 30) revealed that 
the native Epx1pp was completely attached to eGFP (Figure 30, lane 2 to 5) 
even though only low amounts were detected. In contrast, by using the 
shortened Epx1pp, not all protein was fully processed, but fractions of 
correctly cleaved eGFP were observable (Figure 30, lane 6 to 9). The 
MFα1pp was completely cleaved off, except leaving N-terminal amino acids 
of spacer sequence (Figure 
30, lane 10 to 13). 
 
We performed another 
approach to study 
intracellular eGFP and its 
fluorimetric capability. 
Therefore, the washed cell 
pellets of 12 individual 
clones per construct were 
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analyzed and measured regarding intracellular fluorescence units per mg 
wet cell weight (Figure 31). The obtained results are conclusive with 
intracellular eGFP detected via Western blot, indicating higher intracellular 
expression levels with the shortened Epx1pp (A: 79.84 FU/mg wcw) 
compared to native Epx1pp (A: 20.69 FU/mg wcw), The calculated FU/mg 
wet cell weight of intracellular eGFP with MFα1pp revealed very low levels 
of intracellular eGFP (A: 5.56 FU/mg wcw).  
 
 
 
Immunofluorescence performed by Verena Puxbaum revealed a 
vacuolar eGFP signal for both the native Epx1pp (Figure 32/A.1) and the 
MFα1pp (Figure 32/C.1) mediated secretion. This was also reported for S. 
cerevisiae, suggesting an unknown encoded vacuolar signal within eGFP 
itself (Kunze et al., 1999). Apart from that, eGFP sufficiently entered the 
secretory pathway, but could not be secreted by native Epx1pp. An intense 
intracellular fluorescent signal by using the shortened Epx1pp-eGFP 
construct was observed (Figure B.1), indicating Golgi (often appearing as 
small dots) or pre-vacuolar compartment stain as well as cytosolic 
background (Figure 32/B.1). The same localization pattern was reported for 
S. cerevisiae, expressing high levels of intracellular eGFP with acid 
phosphatase secretion leader, yet without secretion (Li et al., 2002). 
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6 Discussion 
6.1 Transcriptional regulation of Epx1 expression 
Epx1 was identified as one of the major native extracellular proteins in 
P. pastoris under various different conditions. Microarray data from different 
cultivations of P. pastoris X-33 revealed that EPX1 (RPPA09240) is up-
regulated at 30°C compared to 20°C, but shows similar expression profiles 
at 25°C and 30°C. No increase was shown at overexpression of the 
oxidative stress response transcription factor YAP1 (Delic et al., in 
preparation), but the overexpression of the unfolded protein response 
transcription factor HAC1 (which is also involved in regulation of cell wall 
synthesis; Graf et al., 2008) led to two-fold up-regulation (fold change 
values) and high osmolarity also induced up-regulation (Dragosits et al., 
2010). 
Searching for transcription factor (TF) binding sites in the putative 
promoter region (within 1,000 bp upstream of ATG) revealed no conclusive 
results, but indicated potential binding sites for Stre5 (stress induced TF), 
Gcn4 (amino acid stress TF), Hstf (heat shock TF) and Mcm1 (TF involved 
in extracellular matrix remodeling), just to name a few.  
Gcn4p was identified to be required for induction of UPR target genes 
during ER stress, providing further regulation in UPR response and 
additionally mediating protein degradation under starvation. It was 
suggested that Hac1p and Gcn4p act together in fine-tuning UPR response 
(Patil, Li & Walter, 2004). Presumably, Hac1p stabilizes Gcn4p as they form 
heterodimeric, ternary complexes at a conserved palindromic sequence. 
Therefore, two-fold up-regulation of EPX1 observed at HAC1 
overexpression (Graf et al., 2008) is conclusive. Furthermore, these results 
imply that Epx1 may be involved in stress response. 
Some similarities in pro-sequence processing were assumed between 
Epx1 and yapsins, a class of endopeptidases. Another connection might be 
their involvement in cell wall remodeling. Yapsins are key players in the cell 
surface integrity pathway and cell separation (Albrecht et al., 2006). No 
other results have been obtained for EPX1 except a Mcm1 transcription 
factor binding site, which regulates extracellular matrix remodeling. 
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The promoter analysis revealed that PEPX1 is no strong promoter 
compared to the constitutive PGAP promoter. The 1,000 bp upstream of ATG 
were additionally studied concerning growth on three different carbon 
sources. Population analysis of eGFP expression indicated that the tested 
promoter sequence is not sufficient for high level recombinant protein 
production.  
Additionally, as mentioned in the introduction, high abundance of Epx1 
can still be explained (apart from promoter strength) through either high 
translation efficiency, high protein stability or several other factors. In 
general, the total amount of native secreted protein was rather low (500 mg) 
compared to the high biomass (25 g) obtained at cultivation end, and the 
therefore high intracellular protein levels. 
 
6.2 Impact of native Epx1 secretion leader pro-sequence on 
recombinant proteins 
The native Epx1 pro-sequence comprises 37 amino acids and includes 
two distinctive amino acid motifs; one dibasic motif (Lys-Arg) and one 
monobasic motif (Arg-Thr), whereafter the pro-sequence is cleaved on 
native Epx1 (Figure 15). Each of the three tested recombinant proteins had 
severe difficulties in leader processing, resulting in the secretion of 
unwanted fusion proteins and/or ERAD induced degradation. We assumed 
that correct processing is disturbed by one or both basic motifs. 
Porcine trypsinogen was unsuccessfully secreted by native Epx1pp. In 
comparison to MFα1pp, half as much trypsinogen had been detected in the 
supernatant, but the protein smear indicated difficulties in cleaving the pro-
peptide (Figure 16). Interestingly, enterokinase activation transformed the 
smear to correct size trypsin by hexapeptide (and remaining pro-sequence) 
removal (Figure 17). As SDS-PAGE analysis was accomplished with 
denatured and reduced samples, it is precluded that the smear appears due 
to incorrect folding and processing of pTRP. Autocatalytic activities of 
trypsin itself may also contribute to the protein smear. 
Human serum albumin was partially processed after the monobasic, 
predicted leader end, and at the dibasic motif within the Epx1 pro-sequence 
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(Figure 21). Here, we suppose that the processing speed, respectively the 
accessibility to the processing site due to secondary structures (discussed 
below), is responsible for the double band. Immunofluorescence staining 
revealed only periplasmatic and bud staining, indicating fast and efficient 
secretion of HSA with the native Epx1 leader. Monobasic sites are slower 
cleaved, eventually aided by a co-factor which is lost in time (Schwartz, 
1986). Therefore it is likely that Kex2 cleaves at dibasic sites in the 
meantime, leading to secretion of a dibasic processed fraction.  
Enhanced green fluorescent protein failed to be secreted by the native 
Epx1 secretion leader. Interestingly, intracellular measurement of 
fluorescence units was higher than expected referring to Western blot 
analysis. Blotting revealed that eGFP was still attached to the native Epx1 
secretion leader (Figure 30). This probably impairs structural requirements 
for folding, leading to vacuolar degradation, but eGFP is also assumed to 
contain an intramolecular vacuolar sorting signal (Kunze et al., 1999). 
Consequently, a strong signal was detected by immunofluorescence 
staining, indicating vacuolar targeting (Figure 32).  
It is accepted widely that every leader has different impact on 
recombinant proteins. Folding is supported or impaired by the secretion 
leader, and the cleavage site is better or worse accessible for processing 
enzymes. The amino acid sequence surrounding the monobasic cleavage 
site is important and different at the C-terminus for every single protein. Devi 
(Devi, 1991) reported some common rules and tendencies for cleavage at 
monobasic sites, apart from the proline-directed and non-proline directed 
postulation by Schwartz (Schwartz, 1986). For all three tested recombinant 
proteins within our studies, none of those predictions were completely 
applicable or not.  
 
6.3 Impact of shortened Epx1 secretion leader pro-sequence on 
recombinant proteins 
The shortened Epx1 secretion leader was expected to improve 
secretion and processing, by generating the Kex2 favored cleavage site 
(Figure 22). We suspected that by omitting one of the two potential 
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processing sites, secretion would be enhanced as no concurring processes 
would interfere.  
As expected, the shortened leader enhanced porcine trypsinogen 
secretion (Figure 24). The N-terminal hexapeptide (Thr-[Asp]4-Lys) might be 
exposed to the surface, as it is chipped off leading to activation of trypsin, 
improving adjacent endoproteolytic cleavage by Kex2. This structural 
feature might simultaneously enhance Kex2 processing as fungal Kex2-like 
proteins also show a stretch of four Asp residues subsequent to the Lys-Arg 
motif (Bader et al., 2008). This is also reported for MFα1pp, where 
processing is improved by addition of a spacer peptide (Brake et al., 1983).  
Under the control of PGAP, the shortened Epx1 secretion leader is 
promising (approximately 100 µg trypsinogen per gram wet cell weight) and 
screenings under the control of PAOX1 might enhance secretion even more. 
Notably in P. pastoris, under the regulated control of PAOX1, the expression 
of MFα1pp fused to shrimp trypsinogen yielded 14 mg/L (Guerrero-Olazarán 
et al., 2009) respectively 10 mg/L bovine trypsinogen, where high protein 
levels were reached by using the MFα1pp and HSA secretion signal, and by 
additional removal of enterokinase cleavage site for inactivating bovine 
trypsinogen (Hanquier et al., 2003). 
However, HSA fails to be secreted by the shortened Epx1 secretion 
leader (Figure 25). This is unexpected, because native HSA leader also 
ends with a dibasic (Arg-Arg) motif. The dibasic motif (Lys-Arg) of the 
shortened Epx1 leader is followed by Asp-Ala at P1’ and P2’ of HSA, which 
is in fact an optimal Kex2 cleavage site. HSA was rather subjected to 
cytosolic localization indicating ER-associated degradation, as observed 
with immunofluorescence staining (Figure 28). A possible explanation for 
those results might be the hydrophobicity of the pro-sequence, interfering 
with folding of HSA. 
Enhanced green fluorescent protein was successfully secreted by the 
shortened leader (Figure 29). Western blot analysis revealed that in contrast 
to MFα1pp, no N-terminal extensions were observable. Measurement of 
intracellular fluorescence (FU/wcw) suggested correct folding of eGFP, 
albeit a fraction of intracellular eGFP was located in the cytosol 
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(immunofluorescence staining). Therefore we propose that the Epx1 
secretion leader secretes eGFP strongly and fast, leading to unfolded 
fractions and UPR induced degradation. Interestingly, in P. pastoris eGFP 
was secreted efficiently only by the PHA-E (Raemaekers et al., 1999), 
K28pptox (Eiden-Plach et al., 2004) and MFα1pp secretion leader 
(Campbell & Choy, 2002) so far. Here we report efficient secretion of eGFP 
by the MFα1pp secretion leader and the shortened Epx1 secretion leader. 
 
6.4 Influence of secretion leaders on protein stability 
Secretion leaders do have significant impact on secretion efficiency in 
yeast (Sreekrishna et al., 1997). Hydrophobic sequences within the pro-
sequence are also known to serve as binding signal for ER-resident 
chaperones (Otte & Barlowe, 2004). Additionally, the correlation of 
expression and the thermodynamic stability with various signal sequences 
has been reported for recombinant protein production. Silkworm lysozyme 
was unstable when using the MFα1pp, but efficiently secreted by its native 
signal leader. Just four N-terminal amino acids decrease silkworm lysozyme 
thermodynamic stability by half. Expression levels of human lysozyme using 
MFα1pp were more than 100 times higher, even though leading to a mixture 
of several molecular species which correspond to incomplete processing at 
the C-terminus (Koganesawa et al., 2001).  
Less stable proteins are easily degraded by proteases, which causes a 
decrease in total expression yield and UPR induction (Patil & Walter, 2001). 
The possible relationship between protein stability in accordance to its 
secretion signal is likely and should also be taken into consideration for the 
Epx1 secretion leader.  
 
6.5 Consensus sequence and structural requirements at 
monobasic and dibasic processing sequences 
As it is difficult to make general statements about leader characteristics 
on structurally and functionally diverse proteins, we tried to find reasonable 
explanations on Epx1 itself. The native leader led to secreted recombinant 
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proteins processed at the predicted monobasic leader end and fractions 
which were cleaved at the dibasic motif. We therefore hypothesize that the 
native leader incorporates specific features only necessary for Epx1, 
supported by improved secretion of recombinant proteins after removing the 
C-terminal part of the pro-sequence after Lys-Arg. 
Since not all mono- or dibasic sites are substrate for endoproteolytic 
cleavage, it is suggested that secondary and tertiary structures are 
important in generating a conformation, which is recognized by cleavage 
enzymes. Structural features within the Epx1 pro-peptide are rather 
recognized by Kex2 endoprotease as is the mature peptide. 20 different 
prohormones sequences with 53 dibasic potential cleavage sites have been 
compared, concluding that dibasic motifs, which are located in or next to ß-
turns are cleaved (as they are more likely exposed to the surface), whereas 
location in or next to ß-sheets or α-helices did not allow cleavage (Brakch et 
al., 1993).  
This prediction is most likely valid for Epx1 pro-sequence. The Lys-Arg 
motif is located within a β-turn (Figure 33), predicted by an empirical 
technique for the first 60 N-terminal amino acids, developed by Chou and 
Fasman (Chou & Fasman, 1974) and its improved algorithm (Garnier, 
Osguthorpe & Robson, 1978). Both algorithms were applied for structural 
prediction by using the University of Virginia 
(http://fasta.bioch.virginia.edu/fasta_www2/fasta_www.cgi?rm=misc1) 
server.  
As we started analyzing Epx1pp’s secretion efficiency on recombinant 
proteins, we observed processing difficulties of the pro-sequence. It failed to 
be cleaved exclusively at the expected monobasic site, leading to an 
Epx1pp-pTRP fusion protein smear and approximately half of HSA 
remaining attached to the pro-sequence. The β-turn accounts for the key 
feature in proteolytic processing so far and, according to the GOR plot in 
Figure 33/B, Epx1pp pro-sequence includes two β-turns. One was predicted 
at the dibasic motif, matching with partially processed native Epx1 secretion 
leader observed with HSA. However, no prediction for monobasic sites at β-
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turns were made, but LKP was determined as N-terminal, extracellular end 
of Epx1, coinciding with this hypothesis (Figure 33/B; red dot).  
 
 
 
Additionally, Kex2 processing is favored by His at position P3 and small 
or negatively charged residues in the P1´, P2´ position; also found in Epx1 
pro-sequence. Furthermore, Bader and colleagues reported that denatured 
substrates were less efficiently processed, suggesting that either the 
cleavage site is inaccessible or a required secondary structure was lost 
(Bader et al., 2008). 
It was also reported that Kex2 itself (soluble or Golgi persistent) takes 
part as a saturable limiting sorting component in the secretory pathway, as 
Kex2 is also involved in sorting to the vacuole via pre-vacuolar 
compartment. Additionally, secretion of insulin was increased after 
substituting dibasic sites, as well as by vps and kex2 deletions, suggesting 
endoproteolytic processing and sorting of Kex2 being the main cause for 
protein retention and mislocalization to the vacuole (Zhang  et al., 2001). 
In plants, BiP was suggested to carry an additional vacuolar sorting 
signal, which enables an adaptor function between ill-defined hydrophobic 
regions of misfolded proteins with the vacuolar sorting machinery. Vps10 
recognizes hydrophobic regions in proteins determined to vacuolar targeting 
(Pimpl et al., 2006). Furthermore, it has been reported for synthetic leader-
mediated insulin precursor (IP) secretion in S. cerevisiae that binding of BiP 
to hydrophobic sequences protects against ERAD and facilitates folding and 
secretion. The pro-sequence was therefore suspected to function as 
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intramolecular chaperones mediating pro-peptide assisted folding. An α-
helix within the pro-sequence was assumed to fold back upon the IP, thus 
stabilizing by interaction with the α-helix of the peptide (Kjeldsen et al., 
1997). BiP recognizes a motif of bulky hydrophobic and aromatic residues, 
recognizing a wide variety of polypeptide sequences, which are normally 
buried in the interior of a folded protein (Blond-Elguindi et al., 1993). Epx1 
pro-sequence is highly hydrophobic (Figure 15), but BiP binding probability 
(according to Blond-Elguindi) needs to be calculated. Apart from that, Epx1 
shows an α-helical region within the native pro-sequence (Figure 33), which 
could also assist in folding.  
 
6.6 Processing possibilities of Epx1 pro-sequence 
We suggest two possible roles for the additional dibasic motif within the 
pro-sequence of Epx1. One possibility might be a two-stage cleavage of the 
pro-peptide. The first cleavage at the dibasic Lys-Arg motif is performed by 
Kex2 protease within the late Golgi. Release of Epx1 with pro-sequence into 
secretory vesicles further allows cleavage by a monobasic specific protease 
or direct secretion without subsequent cleavage.  
The 21 remaining amino acids of the pro-sequence comprise 
hydrophobic amino acids. Accordingly, this peptide might occupy the 
hydrophobic cleft within Epx1 during late secretory pathway until 
dimerization, as also reported for GAPR-1 (human Golgi-associated plant 
pathogenesis related protein) and yapsins (Gagnon-Arsenault et al., 2006; 
Serrano et al., 2004b). As reported for pepsin-like aspartic proteinase A, the 
pro-sequence appears to guide folding of the mature region of PrA (Parr et 
al., 2007).  
Cleavage possibility might be improved by folding the pro-sequence into 
the hydrophobic cleft of Epx1 and exposing the restriction site to monobasic 
processing enzymes, such as yapsins. The predicted β-turn at this position 
is likely to support this activity. 
As described in the previous chapter, BiP may bind the N-terminal part 
of the Epx1 pro-sequence and assist in folding and dimerization. Reported 
for GAPR-1, the pro-sequence might be removed autocatalytically after 
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dimerization. Assuming a two-stage cleavage, the C-terminal part of the pro-
sequence may also is removed immediately prior to dimerization. The 
hydrophobic regions of the GAPR-1 monomers are then accessible and 
promote association. Epx1 is likely to dimerize within the ER, as Epx1 
dimers found extracellularly are predicted to be connected via disulfide 
bonds, but it is unknown whether all of the 4 cysteine residues are involved 
in dimerization. 
A knock out of EPX1 was attempted during this thesis. Positive clones 
were indicated through PCR analysis, but could not be isolated. Cells were 
viable, but had a severely impaired growth. Isolation of epx1 cells was also 
impaired as the knock out cassette was (indicated via PCR) sporadically 
integrated elsewhere, leading to mixed populations. Therefore, the effect of 
processing in an epx1-deletion strain could not be assessed. 
Another possibility is that Epx1 is adjusted to cellular needs by 
differential processing. The specific purpose of Epx1 is not yet known and 
sequence alignment predicted only C-terminal homology to SCP-family 
members (Figure 6). Hypothesizing that Epx1 is upregulated under cellular 
stress (described above) and taken into account that monobasic sites are 
processed slower compared to dibasic sites, it might be possible that this 
differentiated processing serves as switch for adjustment.  
Aspartic proteases were first described as monobasic and dibasic 
processing enzymes which additionally compensate dibasic cleavage in 
Kex2 deficient yeast (Bourbonnais et al., 1991). A precise distinction 
between monobasic and dibasic cleavage mechanisms occurs for many 
precursor proteins in mammalian cells. The same primary translation 
product can be processed differently in different tissues, e. g. pro-
opiomelanocortin (Estivariz, Birch & Loh, 1989), somatostatin (Bourbonnais 
et al., 1991) and glucagon (Dey et al., 2005). Most prohormones are 
cleaved in the secretory vesicle at specific sites yielding biologically active 
peptides (Halban & Irminger, 1994). 
On the one hand, Kex2 protease is a saturable enzyme under protein 
production conditions, leading to partial cleavage at dibasic sites and 
vacuolar targeting. On the other hand, this might be desirable, as it offers 
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processing opportunity for monobasic specific endoproteases. Observed for 
mammalian prohormones, cleavage at either site is tissue specific. 
Therefore, we do not exclude this hypothesis, even though it is less likely 
than the assumption described previously.  
Notably, the C-terminal amino acids after the Lys-Arg motif of the pro-
sequence do not predict a specific sorting signal, as the shortened Epx1 
secretion leader also led to secretion.  
 
6.7 Processing of the Epx1 pro-sequence by aspartic proteases 
(yapsins) 
The pro-sequence of Epx1pp as well as of the aspartic-protease family 
(including yapsins) contain a dibasic and monobasic amino acid motif. 
Especially for secreting HSA with the native Epx1 secretion leader, two 
molecular species were observed, and determined to be processed at either 
side. Yapsins are assumed to process at the monobasic motif. They 
themselves contain basic motifs within the pro-sequence and the 
polypeptide. In vitro expression analysis of yapsin 1 indicated that yapsin 1 
is cleaved and processed additionally after intramolecular monobasic motifs, 
leading to a heterodimer, stabilized by an intramolecular disulfide bond 
(Cawley et al., 1998).  
Yapsins contain heterogeneous glysocylation and a GPI anchor, as it is 
a characteristic of yeast periplasmic and cell wall proteins (Ash et al., 1995; 
Komano et al., 1999). Epx1 is neither glycosylated nor possessing a GPI-
anchor. Therefore, processing is suspected to happen in the secretory 
vesicles. Autocatalytic activation might be possible for Epx1 as it has been 
proposed that the SCP-domain may functions as endopeptidase (NCBI, 
conserved domain database, cd05380), but cannot be outlined until studies 
on native Epx1 have been performed. In contrast, the fungal yapsin Sap9 
has been indicated to enclose an autocatalytic processing ability (Albrecht 
et al., 2006). In comparison to other PR-1 family members, for GAPR-1 it 
was reported that conserved residues of the putative serine protease 
catalytic triad are distributed across the two independent molecules of the 
dimer (Serrano et al., 2004b). 
84 
 
Several studies implicate cleavage of yapsins exclusively C-terminal of 
a basic residue (Komano et al., 1999). Its negatively charged active pocket 
tightly interacts with basic residues at P1. As determined by Edman 
sequencing analysis, Epx1pp pro-sequence was cleaved after Thr at P1, 
with the basic amino acid Arg at P2. This cleavage is untypical for 
monobasic motifs, where Arg is dominantly at P1. For yapsin 1, it was 
reported that a basic residue at P1 is most likely, but cleavage efficiency 
was enhanced with Arg residues flanking the P1 position (Olsen et al., 
1998), as it is the case for Epx1. Therefore we suspect that Epx1 
processing at the monobasic motif is mediated by yapsins . 
  
85 
 
 
6.8 Conclusion 
In this study, we analyzed the effect of the pro-sequence of an unknown 
extracellular protein on the secretion of three structurally and functionally 
different recombinant proteins.  
Apparently, the results obtained indicate that the native Epx1 secretion 
leader is not applicable on its own for other proteins as it was not completely 
chipped off. In this respect, processing of the substrate does not only 
depend on the amino acid sequence surrounding the processing site, but 
also on other features such as three dimensional structures. 
Within the pro-sequence, a potential Kex2 cleavage site (dibasic Lys-
Arg) was identified. Removing 21 amino acids, subsequent to the dibasic 
Lys-Arg motif, enhanced secretion of two out of three tested proteins without 
immunogenic N-terminal overhangs. Further studies on Epx1 are necessary 
to elucidate the function of the function of Epx1 protein and the C-terminal 
21 amino acids of its secretion leader. In accordance to the results obtained 
with the shortened leader, we postulate that the pro-segment is unessential 
and disturbing for other proteins than Epx1. Moreover, the shortened Epx1 
secretion leader is the first described from the SCP-family. Equally 
important, it enhanced pTRP secretion (14 %) in comparison to the MFα1pp 
secretion leader and enabled eGFP secretion in P. pastoris.  
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8 Appendix 
8.1 Abbreviations 
 
°C degree centigrade 
µ micro 
A average 
AP alkaline phosphatase 
bp base pair(s) 
BSA bovine serum albumin 
ddH2O reverse osmosis water 
dNTP deoxynucleoside triphosphate 
EDTA ethylenediaminetetraacetic acid 
et al. and others 
g gram 
g gravitational force 
h hour(s) 
HEPES 4-(2-hydroxyethyl)-1- piperazineethanesulfonic acid 
HRP horse radish peroxidase 
IgG immunoglobulin G 
kb kilo base(s) 
kDa kilo Dalton 
L liter 
LB lysogeny broth 
LDS lithium dodecyl sulfate 
M mol 
m milli or meter 
min minute(s) 
MOPS 3-(N-morpholino)propanesulfonic acid 
N normality (mol/L) 
n nano 
OD optical density 
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OPD o-phenylenediamine 
ORF open reading frame 
PAGE polyacrylamide gel electrophoresis 
PBS/PBST phosphate buffered saline/ plus Tween20 
pI isoelectric point 
rpm revolutions per minute 
RT room temperature 
s second(s) 
SD standard deviation 
SDS sodium dodecyl sulfate 
SOC super optimal broth with catabolite repression 
TAE Tris base, acetic acid and EDTA 
Tris 2-amino-2-(hydroxymethyl)-1,3-propanediol 
U unit(s) of activity 
UV ultra violet 
wcw wet cell weight 
wt wild type 
x -fold 
YPD yeast extract peptone dextrose 
α alpha or anti 
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8.3 Zusammenfassung 
 
Die methylotrophe Hefe Pichia pastoris gilt als beliebtes 
Expressionssystem zur Produktion von rekombinanten Proteinen. Die 
Verfügbarkeit sowohl von starken Promotoren (z.B. der Glyceraldehyd-3-
Phosphat Dehydrogenase Promoter, PGAP und den Promoter der Alkohol 
Oxidase, PAOX1) und effizienten Sekretionssignalen (alpha mating factor 
Sekretionssignal; MF1αpp), als auch eine funktionierende Proteinfaltung und 
das Anfügen von post-translationalen Modifikationen sind vorteilhaft.  
Das extrazelluläre Protein X (Epx1) wurde als stark sekretiertes, jedoch 
unbekanntes Protein im Überstand von P. pastoris bemerkt. Wenig ist 
bekannt über Epx1, außer dass es eines von 20 endogen sekretierten 
Proteinen ist und der C-Terminus mit einer SCP-ähnlichen (sekretiert und 
Cystein-reich) extrazellulären Proteindomäne überein stimmt. Die 
Anwendbarkeit als neues Sekretionssystem für rekombinante Proteine wurde 
anhand von intrazellulärer eGFP Expression durch den Promoter (1.000 bp 
oberhalb des ATG) auf drei unterschiedlichen Kohlenstoffquellen getestet. 
PEPX1 zeigte keine verbesserte eGFP Sekretion, verglichen mit PGAP. Weiters 
wurde das Epx1 Sekretionssignal mit drei strukturell und funktionell 
unterschiedlichen Proteinen analysiert (pTRP, porcines Trypsinogen; HSA, 
humanes Serumalbumin; eGFP, verbessertes grün-fluoreszierendes Protein). 
Die Sekretionssequenz von Epx1 wurde teilweise nicht korrekt 
abgespalten. 21 Aminosäuren der Pro-Sequenz wurden, auf Grund von 
unerwarteter Spaltung an einer internen Sequenz (zwei basische 
Aminosäuren), nicht abgespalten und blieben am N-Terminus. Wir verkürzten 
die Sequenz und erzielten (im Vergleich zu MFα1pp) eine Steigerung der 
pTRP Sekretion, als auch Sekretion von eGFP ohne N-terminalen Überhang. 
Zusammenfassend haben wir durch Verkürzung der Epx1-Pro-Sequenz eine 
neue, effiziente Sekretionssequenz geschaffen.  
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